TWI863271B

TWI863271B - 用於調節ｃｏｔ之化合物之固體形式

用於調節ｃｏｔ之化合物之固體形式 Download PDF

Info

Publication number: TWI863271B
Authority: TW; Taiwan
Prior art keywords: formula; degrees; reflections; solid form; inhibitors
Prior art date: 2022-05-12

Application number

TW112117450A

Other languages

English (en)

Chinese (zh)

Other versions

TW202400161A (zh

Inventor

爾內斯特 A 卡拉

盈盈陳

大輔齋藤

Original Assignee

美商基利科學股份有限公司

Priority date

2022-05-12

Filing date

2023-05-11

Publication date

2024-11-21

2023-05-11 Application filed by 美商基利科學股份有限公司 filed Critical 美商基利科學股份有限公司

2024-01-01 Publication of TW202400161A publication Critical patent/TW202400161A/zh

2024-11-21 Application granted granted Critical

2024-11-21 Publication of TWI863271B publication Critical patent/TWI863271B/zh

Links

239000007787 solid Substances 0.000 title claims abstract description 265
150000001875 compounds Chemical class 0.000 title abstract description 140
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 23
238000001757 thermogravimetry curve Methods 0.000 claims description 109
238000002411 thermogravimetry Methods 0.000 claims description 66
238000000113 differential scanning calorimetry Methods 0.000 claims description 54
238000002441 X-ray diffraction Methods 0.000 claims description 34
239000003814 drug Substances 0.000 claims description 21
229940124597 therapeutic agent Drugs 0.000 claims description 8
238000001179 sorption measurement Methods 0.000 claims description 7
239000002552 dosage form Substances 0.000 claims description 6
239000003937 drug carrier Substances 0.000 claims description 6
208000027866 inflammatory disease Diseases 0.000 claims description 5
238000004949 mass spectrometry Methods 0.000 claims description 3
238000000034 method Methods 0.000 abstract description 46
238000011282 treatment Methods 0.000 abstract description 15
230000001404 mediated effect Effects 0.000 abstract description 4
238000000634 powder X-ray diffraction Methods 0.000 description 610
239000003112 inhibitor Substances 0.000 description 317
239000005557 antagonist Substances 0.000 description 93
239000000203 mixture Substances 0.000 description 80
239000003446 ligand Substances 0.000 description 77
150000003839 salts Chemical class 0.000 description 71
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 59
238000001938 differential scanning calorimetry curve Methods 0.000 description 55
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 53
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 51
239000000556 agonist Substances 0.000 description 51
229940044551 receptor antagonist Drugs 0.000 description 50
239000002464 receptor antagonist Substances 0.000 description 49
235000015895 biscuits Nutrition 0.000 description 47
238000005481 NMR spectroscopy Methods 0.000 description 42
HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical class OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 41
239000002904 solvent Substances 0.000 description 38
WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical class COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 38
IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 description 36
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 36
QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical class OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 36
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 35
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 35
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 33
201000010099 disease Diseases 0.000 description 33
JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 32
KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical class C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 31
230000001747 exhibiting effect Effects 0.000 description 29
SJJCQDRGABAVBB-UHFFFAOYSA-N 1-hydroxy-2-naphthoic acid Chemical class C1=CC=CC2=C(O)C(C(=O)O)=CC=C21 SJJCQDRGABAVBB-UHFFFAOYSA-N 0.000 description 28
YGTUPRIZNBMOFV-UHFFFAOYSA-N 2-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(=O)C1=CC=C(O)C=C1 YGTUPRIZNBMOFV-UHFFFAOYSA-N 0.000 description 28
TYEYBOSBBBHJIV-UHFFFAOYSA-N 2-oxobutanoic acid Chemical class CCC(=O)C(O)=O TYEYBOSBBBHJIV-UHFFFAOYSA-N 0.000 description 28
-1 hydrate Substances 0.000 description 28
229940044601 receptor agonist Drugs 0.000 description 28
239000000018 receptor agonist Substances 0.000 description 28
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
239000002253 acid Substances 0.000 description 25
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 25
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 24
239000003795 chemical substances by application Substances 0.000 description 24
239000011521 glass Substances 0.000 description 24
239000000543 intermediate Substances 0.000 description 24
238000001107 thermogravimetry coupled to mass spectrometry Methods 0.000 description 24
235000019441 ethanol Nutrition 0.000 description 23
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 22
108090000623 proteins and genes Proteins 0.000 description 21
PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 20
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 19
QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 19
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
150000001558 benzoic acid derivatives Chemical class 0.000 description 18
238000000354 decomposition reaction Methods 0.000 description 18
150000002688 maleic acid derivatives Chemical class 0.000 description 18
XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 18
229960004618 prednisone Drugs 0.000 description 18
238000005119 centrifugation Methods 0.000 description 17
229940011051 isopropyl acetate Drugs 0.000 description 17
GWYFCOCPABKNJV-UHFFFAOYSA-M isovalerate Chemical compound CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 17
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
239000003909 protein kinase inhibitor Substances 0.000 description 16
235000018102 proteins Nutrition 0.000 description 16
102000004169 proteins and genes Human genes 0.000 description 16
150000004728 pyruvic acid derivatives Chemical class 0.000 description 16
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 15
229940121649 protein inhibitor Drugs 0.000 description 15
239000012268 protein inhibitor Substances 0.000 description 15
102000005962 receptors Human genes 0.000 description 15
108020003175 receptors Proteins 0.000 description 15
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 description 14
239000000243 solution Substances 0.000 description 14
238000006243 chemical reaction Methods 0.000 description 13
239000012535 impurity Substances 0.000 description 13
238000012360 testing method Methods 0.000 description 13
ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical class OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 12
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
239000001569 carbon dioxide Substances 0.000 description 12
229910002092 carbon dioxide Inorganic materials 0.000 description 12
238000004519 manufacturing process Methods 0.000 description 12
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 12
239000000725 suspension Substances 0.000 description 12
239000005483 tyrosine kinase inhibitor Substances 0.000 description 12
AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 11
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 11
150000001860 citric acid derivatives Chemical class 0.000 description 11
229940079593 drug Drugs 0.000 description 11
238000001914 filtration Methods 0.000 description 11
239000000463 material Substances 0.000 description 11
PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 11
229940121358 tyrosine kinase inhibitor Drugs 0.000 description 11
108010050904 Interferons Proteins 0.000 description 10
102000014150 Interferons Human genes 0.000 description 10
108060008682 Tumor Necrosis Factor Proteins 0.000 description 10
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 10
WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 10
239000012346 acetyl chloride Substances 0.000 description 10
229940079322 interferon Drugs 0.000 description 10
VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 10
238000003756 stirring Methods 0.000 description 10
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 9
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 9
229910019142 PO4 Inorganic materials 0.000 description 9
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 9
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
239000004480 active ingredient Substances 0.000 description 9
239000003054 catalyst Substances 0.000 description 9
230000008859 change Effects 0.000 description 9
229960000485 methotrexate Drugs 0.000 description 9
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 9
239000010452 phosphate Substances 0.000 description 9
238000002360 preparation method Methods 0.000 description 9
239000000047 product Substances 0.000 description 9
239000000126 substance Substances 0.000 description 9
102000015696 Interleukins Human genes 0.000 description 8
108010063738 Interleukins Proteins 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
238000004458 analytical method Methods 0.000 description 8
210000004027 cell Anatomy 0.000 description 8
238000001035 drying Methods 0.000 description 8
238000009472 formulation Methods 0.000 description 8
230000001976 improved effect Effects 0.000 description 8
229910052757 nitrogen Inorganic materials 0.000 description 8
208000024891 symptom Diseases 0.000 description 8
108060003951 Immunoglobulin Proteins 0.000 description 7
241001465754 Metazoa Species 0.000 description 7
BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 7
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 7
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 7
102000011011 Sphingosine 1-phosphate receptors Human genes 0.000 description 7
108050001083 Sphingosine 1-phosphate receptors Proteins 0.000 description 7
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
210000001744 T-lymphocyte Anatomy 0.000 description 7
230000015572 biosynthetic process Effects 0.000 description 7
JYWJULGYGOLCGW-UHFFFAOYSA-N chloromethyl chloroformate Chemical compound ClCOC(Cl)=O JYWJULGYGOLCGW-UHFFFAOYSA-N 0.000 description 7
102000018358 immunoglobulin Human genes 0.000 description 7
229940043355 kinase inhibitor Drugs 0.000 description 7
238000004811 liquid chromatography Methods 0.000 description 7
229940076788 pyruvate Drugs 0.000 description 7
229960004641 rituximab Drugs 0.000 description 7
239000002352 surface water Substances 0.000 description 7
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 6
108010036949 Cyclosporine Proteins 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
241000124008 Mammalia Species 0.000 description 6
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 description 6
108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 description 6
QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 6
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 6
229960001265 ciclosporin Drugs 0.000 description 6
239000003246 corticosteroid Substances 0.000 description 6
229960001334 corticosteroids Drugs 0.000 description 6
239000013078 crystal Substances 0.000 description 6
229930182912 cyclosporin Natural products 0.000 description 6
XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 description 6
229960004171 hydroxychloroquine Drugs 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 description 6
206010039073 rheumatoid arthritis Diseases 0.000 description 6
239000002002 slurry Substances 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
230000000699 topical effect Effects 0.000 description 6
SJJCQDRGABAVBB-UHFFFAOYSA-M 1-hydroxy-2-naphthoate Chemical compound C1=CC=C2C(O)=C(C([O-])=O)C=CC2=C1 SJJCQDRGABAVBB-UHFFFAOYSA-M 0.000 description 5
206010009900 Colitis ulcerative Diseases 0.000 description 5
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 5
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 5
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 5
UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 5
108010090054 Membrane Glycoproteins Proteins 0.000 description 5
102000012750 Membrane Glycoproteins Human genes 0.000 description 5
102100026907 Mitogen-activated protein kinase kinase kinase 8 Human genes 0.000 description 5
102000007399 Nuclear hormone receptor Human genes 0.000 description 5
108020005497 Nuclear hormone receptor Proteins 0.000 description 5
201000006704 Ulcerative Colitis Diseases 0.000 description 5
LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 5
230000008901 benefit Effects 0.000 description 5
230000027455 binding Effects 0.000 description 5
239000002775 capsule Substances 0.000 description 5
230000000694 effects Effects 0.000 description 5
238000001990 intravenous administration Methods 0.000 description 5
229960000681 leflunomide Drugs 0.000 description 5
239000007788 liquid Substances 0.000 description 5
SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 5
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 5
201000008482 osteoarthritis Diseases 0.000 description 5
239000004031 partial agonist Substances 0.000 description 5
239000003757 phosphotransferase inhibitor Substances 0.000 description 5
239000003755 preservative agent Substances 0.000 description 5
229940075993 receptor modulator Drugs 0.000 description 5
239000012453 solvate Substances 0.000 description 5
229960001940 sulfasalazine Drugs 0.000 description 5
NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 5
NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 5
229960001967 tacrolimus Drugs 0.000 description 5
QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 5
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 5
230000001225 therapeutic effect Effects 0.000 description 5
229940080296 2-naphthalenesulfonate Drugs 0.000 description 4
108010011376 AMP-Activated Protein Kinases Proteins 0.000 description 4
102000014156 AMP-Activated Protein Kinases Human genes 0.000 description 4
208000011231 Crohn disease Diseases 0.000 description 4
108010008165 Etanercept Proteins 0.000 description 4
108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 4
102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 4
241000282412 Homo Species 0.000 description 4
201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 4
208000022559 Inflammatory bowel disease Diseases 0.000 description 4
102100022337 Integrin alpha-V Human genes 0.000 description 4
101710123022 Integrin alpha-V Proteins 0.000 description 4
102000013691 Interleukin-17 Human genes 0.000 description 4
108050003558 Interleukin-17 Proteins 0.000 description 4
208000029523 Interstitial Lung disease Diseases 0.000 description 4
208000005777 Lupus Nephritis Diseases 0.000 description 4
102100033127 Mitogen-activated protein kinase kinase kinase 5 Human genes 0.000 description 4
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
229940122144 Prostaglandin receptor antagonist Drugs 0.000 description 4
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
229910052782 aluminium Inorganic materials 0.000 description 4
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
125000003118 aryl group Chemical group 0.000 description 4
125000004429 atom Chemical group 0.000 description 4
229960002170 azathioprine Drugs 0.000 description 4
230000009286 beneficial effect Effects 0.000 description 4
239000011230 binding agent Substances 0.000 description 4
239000006227 byproduct Substances 0.000 description 4
239000000356 contaminant Substances 0.000 description 4
229960004397 cyclophosphamide Drugs 0.000 description 4
239000007857 degradation product Substances 0.000 description 4
239000006185 dispersion Substances 0.000 description 4
239000002532 enzyme inhibitor Substances 0.000 description 4
238000004128 high performance liquid chromatography Methods 0.000 description 4
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
229910000041 hydrogen chloride Inorganic materials 0.000 description 4
230000001965 increasing effect Effects 0.000 description 4
208000036971 interstitial lung disease 2 Diseases 0.000 description 4
150000002689 maleic acids Chemical class 0.000 description 4
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 4
KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 4
208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 4
108020004017 nuclear receptors Proteins 0.000 description 4
229940076155 protein modulator Drugs 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
230000010415 tropism Effects 0.000 description 4
ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 3
IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical compound OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 description 3
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
238000005160 1H NMR spectroscopy Methods 0.000 description 3
OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 3
VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 3
239000005711 Benzoic acid Substances 0.000 description 3
102000015735 Beta-catenin Human genes 0.000 description 3
108060000903 Beta-catenin Proteins 0.000 description 3
108010035532 Collagen Proteins 0.000 description 3
102000004300 GABA-A Receptors Human genes 0.000 description 3
108090000839 GABA-A Receptors Proteins 0.000 description 3
101001018196 Homo sapiens Mitogen-activated protein kinase kinase kinase 5 Proteins 0.000 description 3
102000009490 IgG Receptors Human genes 0.000 description 3
108010073807 IgG Receptors Proteins 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
102000004877 Insulin Human genes 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
108010022222 Integrin beta1 Proteins 0.000 description 3
102000012355 Integrin beta1 Human genes 0.000 description 3
102000003777 Interleukin-1 beta Human genes 0.000 description 3
108090000193 Interleukin-1 beta Proteins 0.000 description 3
102100030703 Interleukin-22 Human genes 0.000 description 3
108090000978 Interleukin-4 Proteins 0.000 description 3
102000004889 Interleukin-6 Human genes 0.000 description 3
108090001005 Interleukin-6 Proteins 0.000 description 3
102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 3
108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 3
102100026888 Mitogen-activated protein kinase kinase kinase 7 Human genes 0.000 description 3
102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 description 3
108010054395 P-selectin ligand protein Proteins 0.000 description 3
108091008606 PDGF receptors Proteins 0.000 description 3
102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 description 3
102000009822 Sterol Regulatory Element Binding Proteins Human genes 0.000 description 3
108010020396 Sterol Regulatory Element Binding Proteins Proteins 0.000 description 3
108090000190 Thrombin Proteins 0.000 description 3
102100031294 Thymic stromal lymphopoietin Human genes 0.000 description 3
102000002689 Toll-like receptor Human genes 0.000 description 3
108020000411 Toll-like receptor Proteins 0.000 description 3
102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
108090001012 Transforming Growth Factor beta Proteins 0.000 description 3
101800002279 Transforming growth factor beta-1 Proteins 0.000 description 3
108010037150 Transient Receptor Potential Channels Proteins 0.000 description 3
102000011753 Transient Receptor Potential Channels Human genes 0.000 description 3
102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 3
229960003697 abatacept Drugs 0.000 description 3
239000012190 activator Substances 0.000 description 3
239000008186 active pharmaceutical agent Substances 0.000 description 3
229960002964 adalimumab Drugs 0.000 description 3
239000000362 adenosine triphosphatase inhibitor Substances 0.000 description 3
238000013019 agitation Methods 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
238000003556 assay Methods 0.000 description 3
229960003270 belimumab Drugs 0.000 description 3
235000010233 benzoic acid Nutrition 0.000 description 3
235000004883 caffeic acid Nutrition 0.000 description 3
229940074360 caffeic acid Drugs 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
208000020832 chronic kidney disease Diseases 0.000 description 3
QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 3
239000003086 colorant Substances 0.000 description 3
235000014510 cooky Nutrition 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
208000033679 diabetic kidney disease Diseases 0.000 description 3
229960000403 etanercept Drugs 0.000 description 3
150000002170 ethers Chemical class 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
239000012065 filter cake Substances 0.000 description 3
235000003599 food sweetener Nutrition 0.000 description 3
229960001743 golimumab Drugs 0.000 description 3
229930195733 hydrocarbon Natural products 0.000 description 3
150000002430 hydrocarbons Chemical class 0.000 description 3
SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 3
229960000598 infliximab Drugs 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
230000003993 interaction Effects 0.000 description 3
229910052740 iodine Inorganic materials 0.000 description 3
239000010410 layer Substances 0.000 description 3
102000004311 liver X receptors Human genes 0.000 description 3
108090000865 liver X receptors Proteins 0.000 description 3
239000000314 lubricant Substances 0.000 description 3
239000011976 maleic acid Substances 0.000 description 3
239000002609 medium Substances 0.000 description 3
229960004584 methylprednisolone Drugs 0.000 description 3
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
201000006417 multiple sclerosis Diseases 0.000 description 3
229960004866 mycophenolate mofetil Drugs 0.000 description 3
RTGDFNSFWBGLEC-SYZQJQIISA-N mycophenolate mofetil Chemical compound COC1=C(C)C=2COC(=O)C=2C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1 RTGDFNSFWBGLEC-SYZQJQIISA-N 0.000 description 3
206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 3
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 3
239000012044 organic layer Substances 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
239000003880 polar aprotic solvent Substances 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
239000011591 potassium Substances 0.000 description 3
229910052700 potassium Inorganic materials 0.000 description 3
LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
229910000160 potassium phosphate Inorganic materials 0.000 description 3
235000011009 potassium phosphates Nutrition 0.000 description 3
150000003180 prostaglandins Chemical class 0.000 description 3
YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
229940107700 pyruvic acid Drugs 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
229960003471 retinol Drugs 0.000 description 3
239000011607 retinol Substances 0.000 description 3
235000020944 retinol Nutrition 0.000 description 3
230000011664 signaling Effects 0.000 description 3
239000011734 sodium Substances 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
150000003431 steroids Chemical class 0.000 description 3
238000003860 storage Methods 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
239000003765 sweetening agent Substances 0.000 description 3
230000002194 synthesizing effect Effects 0.000 description 3
201000000596 systemic lupus erythematosus Diseases 0.000 description 3
229960004072 thrombin Drugs 0.000 description 3
108010029307 thymic stromal lymphopoietin Proteins 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 3
102000009310 vitamin D receptors Human genes 0.000 description 3
108050000156 vitamin D receptors Proteins 0.000 description 3
MSYGAHOHLUJIKV-UHFFFAOYSA-N 3,5-dimethyl-1-(3-nitrophenyl)-1h-pyrazole-4-carboxylic acid ethyl ester Chemical compound CC1=C(C(=O)OCC)C(C)=NN1C1=CC=CC([N+]([O-])=O)=C1 MSYGAHOHLUJIKV-UHFFFAOYSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
239000005541 ACE inhibitor Substances 0.000 description 2
108010027122 ADP-ribosyl Cyclase 1 Proteins 0.000 description 2
102000018667 ADP-ribosyl Cyclase 1 Human genes 0.000 description 2
102000015936 AP-1 transcription factor Human genes 0.000 description 2
108050004195 AP-1 transcription factor Proteins 0.000 description 2
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 2
108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 2
101710137115 Adenylyl cyclase-associated protein 1 Proteins 0.000 description 2
102100027241 Adenylyl cyclase-associated protein 1 Human genes 0.000 description 2
102100027211 Albumin Human genes 0.000 description 2
108010088751 Albumins Proteins 0.000 description 2
102100039702 Alcohol dehydrogenase class-3 Human genes 0.000 description 2
229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 2
102400000345 Angiotensin-2 Human genes 0.000 description 2
101800000733 Angiotensin-2 Proteins 0.000 description 2
102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 2
108010028006 B-Cell Activating Factor Proteins 0.000 description 2
102000011185 B-lymphocyte antigen CD20 Human genes 0.000 description 2
108050001413 B-lymphocyte antigen CD20 Proteins 0.000 description 2
102100026596 Bcl-2-like protein 1 Human genes 0.000 description 2
102100021334 Bcl-2-related protein A1 Human genes 0.000 description 2
108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 2
108091005575 Bromodomain-containing proteins Proteins 0.000 description 2
102000001805 Bromodomains Human genes 0.000 description 2
108010074051 C-Reactive Protein Proteins 0.000 description 2
102100032752 C-reactive protein Human genes 0.000 description 2
108010032088 Calpain Proteins 0.000 description 2
102000007590 Calpain Human genes 0.000 description 2
229940122866 Cannabinoid CB1 receptor inverse agonist Drugs 0.000 description 2
102000003727 Caveolin 1 Human genes 0.000 description 2
108090000026 Caveolin 1 Proteins 0.000 description 2
102000016289 Cell Adhesion Molecules Human genes 0.000 description 2
108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
102000006303 Chaperonin 60 Human genes 0.000 description 2
108010058432 Chaperonin 60 Proteins 0.000 description 2
108010022172 Chitinases Proteins 0.000 description 2
102000012286 Chitinases Human genes 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
101710095468 Cyclase Proteins 0.000 description 2
108090000266 Cyclin-dependent kinases Proteins 0.000 description 2
102000003903 Cyclin-dependent kinases Human genes 0.000 description 2
108010001202 Cytochrome P-450 CYP2E1 Proteins 0.000 description 2
102100024889 Cytochrome P450 2E1 Human genes 0.000 description 2
102000016911 Deoxyribonucleases Human genes 0.000 description 2
108010053770 Deoxyribonucleases Proteins 0.000 description 2
206010012438 Dermatitis atopic Diseases 0.000 description 2
108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 description 2
102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 description 2
101001031598 Dictyostelium discoideum Probable serine/threonine-protein kinase fhkC Proteins 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 description 2
102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 description 2
102000004980 Dopamine D2 Receptors Human genes 0.000 description 2
108090001111 Dopamine D2 Receptors Proteins 0.000 description 2
102000002045 Endothelin Human genes 0.000 description 2
108050009340 Endothelin Proteins 0.000 description 2
108010049003 Fibrinogen Proteins 0.000 description 2
102000008946 Fibrinogen Human genes 0.000 description 2
102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
102100026148 Free fatty acid receptor 1 Human genes 0.000 description 2
102100039997 Gastric inhibitory polypeptide receptor Human genes 0.000 description 2
108010086246 Glucagon-Like Peptide-1 Receptor Proteins 0.000 description 2
108010088406 Glucagon-Like Peptides Proteins 0.000 description 2
102100032882 Glucagon-like peptide 1 receptor Human genes 0.000 description 2
108020004202 Guanylate Kinase Proteins 0.000 description 2
229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 2
102100022054 Hepatocyte nuclear factor 4-alpha Human genes 0.000 description 2
102000004187 Histamine H4 receptors Human genes 0.000 description 2
108090000796 Histamine H4 receptors Proteins 0.000 description 2
102000003964 Histone deacetylase Human genes 0.000 description 2
108090000353 Histone deacetylase Proteins 0.000 description 2
101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 2
101000894929 Homo sapiens Bcl-2-related protein A1 Proteins 0.000 description 2
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 2
101001039199 Homo sapiens Low-density lipoprotein receptor-related protein 6 Proteins 0.000 description 2
101001109508 Homo sapiens NKG2-A/NKG2-B type II integral membrane protein Proteins 0.000 description 2
101000665442 Homo sapiens Serine/threonine-protein kinase TBK1 Proteins 0.000 description 2
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 2
206010021143 Hypoxia Diseases 0.000 description 2
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 2
101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 description 2
102100037852 Insulin-like growth factor I Human genes 0.000 description 2
102100032818 Integrin alpha-4 Human genes 0.000 description 2
108010041012 Integrin alpha4 Proteins 0.000 description 2
108010072621 Interleukin-1 Receptor-Associated Kinases Proteins 0.000 description 2
102000006940 Interleukin-1 Receptor-Associated Kinases Human genes 0.000 description 2
102000003814 Interleukin-10 Human genes 0.000 description 2
108090000174 Interleukin-10 Proteins 0.000 description 2
108090000176 Interleukin-13 Proteins 0.000 description 2
102000010789 Interleukin-2 Receptors Human genes 0.000 description 2
108010038453 Interleukin-2 Receptors Proteins 0.000 description 2
102100036705 Interleukin-23 subunit alpha Human genes 0.000 description 2
108090001007 Interleukin-8 Proteins 0.000 description 2
102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 2
108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 2
102000004195 Isomerases Human genes 0.000 description 2
108090000769 Isomerases Proteins 0.000 description 2
108010024121 Janus Kinases Proteins 0.000 description 2
102000015617 Janus Kinases Human genes 0.000 description 2
229940122245 Janus kinase inhibitor Drugs 0.000 description 2
102100034723 LanC-like protein 2 Human genes 0.000 description 2
101710195374 LanC-like protein 2 Proteins 0.000 description 2
102100040704 Low-density lipoprotein receptor-related protein 6 Human genes 0.000 description 2
102100037611 Lysophospholipase Human genes 0.000 description 2
108020002496 Lysophospholipase Proteins 0.000 description 2
102000001291 MAP Kinase Kinase Kinase Human genes 0.000 description 2
108060006687 MAP kinase kinase kinase Proteins 0.000 description 2
108010029223 MAP kinase kinase kinase 7 Proteins 0.000 description 2
102400001132 Melanin-concentrating hormone Human genes 0.000 description 2
101800002739 Melanin-concentrating hormone Proteins 0.000 description 2
229920000168 Microcrystalline cellulose Polymers 0.000 description 2
102000016776 Midkine Human genes 0.000 description 2
108010092801 Midkine Proteins 0.000 description 2
102100023482 Mitogen-activated protein kinase 14 Human genes 0.000 description 2
102100025207 Mitogen-activated protein kinase kinase kinase 11 Human genes 0.000 description 2
101710164353 Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 2
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
102100022682 NKG2-A/NKG2-B type II integral membrane protein Human genes 0.000 description 2
UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
101150041793 Nfe2l2 gene Proteins 0.000 description 2
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
102000023159 Platelet Glycoprotein GPIb-IX Complex Human genes 0.000 description 2
108010045766 Platelet Glycoprotein GPIb-IX Complex Proteins 0.000 description 2
102100040678 Programmed cell death protein 1 Human genes 0.000 description 2
101710089372 Programmed cell death protein 1 Proteins 0.000 description 2
108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
108010015499 Protein Kinase C-theta Proteins 0.000 description 2
102100021566 Protein kinase C theta type Human genes 0.000 description 2
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
102100024735 Resistin Human genes 0.000 description 2
108010047909 Resistin Proteins 0.000 description 2
102100038192 Serine/threonine-protein kinase TBK1 Human genes 0.000 description 2
102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 2
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
102100021495 Solute carrier family 22 member 12 Human genes 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
102000019197 Superoxide Dismutase Human genes 0.000 description 2
108010012715 Superoxide dismutase Proteins 0.000 description 2
108091008874 T cell receptors Proteins 0.000 description 2
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 2
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
108091005735 TGF-beta receptors Proteins 0.000 description 2
108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 2
208000033781 Thyroid carcinoma Diseases 0.000 description 2
208000024770 Thyroid neoplasm Diseases 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
239000004012 Tofacitinib Substances 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 description 2
102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 2
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 2
108010040002 Tumor Suppressor Proteins Proteins 0.000 description 2
102000001742 Tumor Suppressor Proteins Human genes 0.000 description 2
102100040247 Tumor necrosis factor Human genes 0.000 description 2
102000011017 Type 4 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 description 2
108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 description 2
108091008605 VEGF receptors Proteins 0.000 description 2
102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 2
229940121373 acetyl-coa carboxylase inhibitor Drugs 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000009471 action Effects 0.000 description 2
239000000654 additive Substances 0.000 description 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
239000003888 alpha glucosidase inhibitor Substances 0.000 description 2
102000030484 alpha-2 Adrenergic Receptor Human genes 0.000 description 2
108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 description 2
229910000147 aluminium phosphate Inorganic materials 0.000 description 2
239000002333 angiotensin II receptor antagonist Substances 0.000 description 2
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
239000003435 antirheumatic agent Substances 0.000 description 2
230000006907 apoptotic process Effects 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
201000008937 atopic dermatitis Diseases 0.000 description 2
230000006399 behavior Effects 0.000 description 2
229940125388 beta agonist Drugs 0.000 description 2
239000002876 beta blocker Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
229940046731 calcineurin inhibitors Drugs 0.000 description 2
YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
210000001175 cerebrospinal fluid Anatomy 0.000 description 2
229960003115 certolizumab pegol Drugs 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000000460 chlorine Substances 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
229920001436 collagen Polymers 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
229940111134 coxibs Drugs 0.000 description 2
239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 2
238000007405 data analysis Methods 0.000 description 2
230000034994 death Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000010511 deprotection reaction Methods 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
229940090124 dipeptidyl peptidase 4 (dpp-4) inhibitors for blood glucose lowering Drugs 0.000 description 2
239000002988 disease modifying antirheumatic drug Substances 0.000 description 2
239000007884 disintegrant Substances 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
YEWZQCDRZRYAEB-UHFFFAOYSA-M ditert-butyl phosphate Chemical compound CC(C)(C)OP([O-])(=O)OC(C)(C)C YEWZQCDRZRYAEB-UHFFFAOYSA-M 0.000 description 2
239000000975 dye Substances 0.000 description 2
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
229940012952 fibrinogen Drugs 0.000 description 2
229940126864 fibroblast growth factor Drugs 0.000 description 2
239000007789 gas Substances 0.000 description 2
108010036598 gastric inhibitory polypeptide receptor Proteins 0.000 description 2
XOXYHGOIRWABTC-UHFFFAOYSA-N gentisin Chemical compound C1=C(O)C=C2C(=O)C3=C(O)C=C(OC)C=C3OC2=C1 XOXYHGOIRWABTC-UHFFFAOYSA-N 0.000 description 2
239000003862 glucocorticoid Substances 0.000 description 2
150000002334 glycols Chemical class 0.000 description 2
238000000227 grinding Methods 0.000 description 2
102000006638 guanylate kinase Human genes 0.000 description 2
229960000890 hydrocortisone Drugs 0.000 description 2
239000004093 hydrolase inhibitor Substances 0.000 description 2
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 2
230000007954 hypoxia Effects 0.000 description 2
229960001680 ibuprofen Drugs 0.000 description 2
239000003018 immunosuppressive agent Substances 0.000 description 2
230000006872 improvement Effects 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
108010074109 interleukin-22 Proteins 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
238000002483 medication Methods 0.000 description 2
ORRDHOMWDPJSNL-UHFFFAOYSA-N melanin concentrating hormone Chemical compound N1C(=O)C(C(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(NC(=O)C(N)CC(O)=O)C(C)O)CCSC)CSSCC(C(=O)NC(CC=2C3=CC=CC=C3NC=2)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)C)C(O)=O)NC(=O)C2CCCN2C(=O)C(CCCNC(N)=N)NC(=O)C1CC1=CC=C(O)C=C1 ORRDHOMWDPJSNL-UHFFFAOYSA-N 0.000 description 2
239000000336 melanocortin receptor agonist Substances 0.000 description 2
KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 2
229960004963 mesalazine Drugs 0.000 description 2
229910052987 metal hydride Inorganic materials 0.000 description 2
150000004681 metal hydrides Chemical class 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
229960002216 methylparaben Drugs 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
239000008108 microcrystalline cellulose Substances 0.000 description 2
229940016286 microcrystalline cellulose Drugs 0.000 description 2
235000019813 microcrystalline cellulose Nutrition 0.000 description 2
230000002438 mitochondrial effect Effects 0.000 description 2
239000002829 mitogen activated protein kinase inhibitor Substances 0.000 description 2
108010041596 mitogen-activated protein kinase kinase kinase 11 Proteins 0.000 description 2
229910052759 nickel Inorganic materials 0.000 description 2
239000003921 oil Substances 0.000 description 2
235000019198 oils Nutrition 0.000 description 2
231100000590 oncogenic Toxicity 0.000 description 2
230000002246 oncogenic effect Effects 0.000 description 2
239000006186 oral dosage form Substances 0.000 description 2
150000007530 organic bases Chemical class 0.000 description 2
108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 2
230000037361 pathway Effects 0.000 description 2
239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
239000000843 powder Substances 0.000 description 2
108060006632 protein arginine deiminase Proteins 0.000 description 2
102000001235 protein arginine deiminase Human genes 0.000 description 2
238000010926 purge Methods 0.000 description 2
150000003242 quaternary ammonium salts Chemical class 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
108091006082 receptor inhibitors Proteins 0.000 description 2
230000004044 response Effects 0.000 description 2
239000012266 salt solution Substances 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
229910052710 silicon Inorganic materials 0.000 description 2
239000010703 silicon Substances 0.000 description 2
238000004467 single crystal X-ray diffraction Methods 0.000 description 2
MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
125000003107 substituted aryl group Chemical group 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
229960004793 sucrose Drugs 0.000 description 2
239000003826 tablet Substances 0.000 description 2
108091008743 testicular receptors 4 Proteins 0.000 description 2
NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
201000002510 thyroid cancer Diseases 0.000 description 2
208000013077 thyroid gland carcinoma Diseases 0.000 description 2
229960001350 tofacitinib Drugs 0.000 description 2
UJLAWZDWDVHWOW-YPMHNXCESA-N tofacitinib Chemical compound C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)C1=NC=NC2=C1C=CN2 UJLAWZDWDVHWOW-YPMHNXCESA-N 0.000 description 2
102000003298 tumor necrosis factor receptor Human genes 0.000 description 2
239000000225 tumor suppressor protein Substances 0.000 description 2
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
230000004580 weight loss Effects 0.000 description 2
229940124629 β-receptor antagonist Drugs 0.000 description 2
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
YUXKOWPNKJSTPQ-AXWWPMSFSA-N (2s,3r)-2-amino-3-hydroxybutanoic acid;(2s)-2-amino-3-hydroxypropanoic acid Chemical compound OC[C@H](N)C(O)=O.C[C@@H](O)[C@H](N)C(O)=O YUXKOWPNKJSTPQ-AXWWPMSFSA-N 0.000 description 1
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
BTBHLEZXCOBLCY-QGZVFWFLSA-N (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide Chemical compound C1([C@@H]2C(=C(C)NC=3C(C)=CN=C(C2=3)OCC)C(N)=O)=CC=C(C#N)C=C1OC BTBHLEZXCOBLCY-QGZVFWFLSA-N 0.000 description 1
HMLGSIZOMSVISS-ONJSNURVSA-N (7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(C=C)CSC21)C(O)=O)=O)C(=O)\C(=N/OCOC(=O)C(C)(C)C)C1=CSC(N)=N1 HMLGSIZOMSVISS-ONJSNURVSA-N 0.000 description 1
GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 1
TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 description 1
ZEUITGRIYCTCEM-KRWDZBQOSA-N (S)-duloxetine Chemical compound C1([C@@H](OC=2C3=CC=CC=C3C=CC=2)CCNC)=CC=CS1 ZEUITGRIYCTCEM-KRWDZBQOSA-N 0.000 description 1
PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
102100031251 1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 Human genes 0.000 description 1
PWJNDVAKQLOWRZ-UHFFFAOYSA-N 1-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=CC=C2C(O)=C(S(O)(=O)=O)C=CC2=C1 PWJNDVAKQLOWRZ-UHFFFAOYSA-N 0.000 description 1
FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
101710188276 14-3-3 protein eta Proteins 0.000 description 1
102100024682 14-3-3 protein eta Human genes 0.000 description 1
GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 1
HKORFDDYEBYGAO-UHFFFAOYSA-N 2-[(4-hydroxyphenyl)methyl]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CC1=CC=C(O)C=C1 HKORFDDYEBYGAO-UHFFFAOYSA-N 0.000 description 1
102100025271 2-acylglycerol O-acyltransferase 2 Human genes 0.000 description 1
101710186725 2-acylglycerol O-acyltransferase 2 Proteins 0.000 description 1
LBORPQYMABOVPW-UHFFFAOYSA-N 2-benzoyl-3-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1C(=O)C1=CC=CC=C1 LBORPQYMABOVPW-UHFFFAOYSA-N 0.000 description 1
XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
FAWLNURBQMTKEB-URDPEVQOSA-N 213546-53-3 Chemical compound N([C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N1[C@@H](CCC1)C(O)=O)C(C)C)C(C)C)C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C FAWLNURBQMTKEB-URDPEVQOSA-N 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
102100022464 5'-nucleotidase Human genes 0.000 description 1
102000049773 5-HT2A Serotonin Receptor Human genes 0.000 description 1
108010072564 5-HT2A Serotonin Receptor Proteins 0.000 description 1
102000006969 5-HT2B Serotonin Receptor Human genes 0.000 description 1
108010072584 5-HT2B Serotonin Receptor Proteins 0.000 description 1
108091005435 5-HT6 receptors Proteins 0.000 description 1
108091005436 5-HT7 receptors Proteins 0.000 description 1
102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 description 1
101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 description 1
239000003406 5-lipoxygenase-activating protein inhibitor Substances 0.000 description 1
MJZJYWCQPMNPRM-UHFFFAOYSA-N 6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine Chemical compound CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC(Cl)=C(Cl)C=C1Cl MJZJYWCQPMNPRM-UHFFFAOYSA-N 0.000 description 1
UIJIQXGRFSPYQW-UHFFFAOYSA-N 6-methylthiopurine Chemical compound CSC1=NC=NC2=C1N=CN2 UIJIQXGRFSPYQW-UHFFFAOYSA-N 0.000 description 1
108010032887 7 beta-hydroxysteroid dehydrogenase Proteins 0.000 description 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
102000051389 ADAMTS5 Human genes 0.000 description 1
108091005663 ADAMTS5 Proteins 0.000 description 1
102000009062 ADP Ribose Transferases Human genes 0.000 description 1
108010049290 ADP Ribose Transferases Proteins 0.000 description 1
108090000067 ADP-Ribosylation Factor 6 Proteins 0.000 description 1
102100039900 ADP-ribosylation factor 6 Human genes 0.000 description 1
108091008803 APLNR Proteins 0.000 description 1
101150071783 APOA1 gene Proteins 0.000 description 1
101150034533 ATIC gene Proteins 0.000 description 1
102000004146 ATP citrate synthases Human genes 0.000 description 1
108090000662 ATP citrate synthases Proteins 0.000 description 1
108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
229940121683 Acetylcholine receptor antagonist Drugs 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
108010052946 Activin Receptors Proteins 0.000 description 1
102000018918 Activin Receptors Human genes 0.000 description 1
102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 1
102000003808 Adiponectin Receptors Human genes 0.000 description 1
108090000179 Adiponectin Receptors Proteins 0.000 description 1
102100022455 Adrenocorticotropic hormone receptor Human genes 0.000 description 1
102400001318 Adrenomedullin Human genes 0.000 description 1
101800004616 Adrenomedullin Proteins 0.000 description 1
102100030805 Adropin Human genes 0.000 description 1
101710161788 Adropin Proteins 0.000 description 1
108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
229940123338 Aldosterone synthase inhibitor Drugs 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
102100038910 Alpha-enolase Human genes 0.000 description 1
101710165425 Alpha-enolase Proteins 0.000 description 1
WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 1
206010068783 Alstroem syndrome Diseases 0.000 description 1
201000005932 Alstrom Syndrome Diseases 0.000 description 1
229910000809 Alumel Inorganic materials 0.000 description 1
108010028700 Amine Oxidase (Copper-Containing) Proteins 0.000 description 1
102000005590 Anaphylatoxin C5a Receptor Human genes 0.000 description 1
102100025668 Angiopoietin-related protein 3 Human genes 0.000 description 1
101710085848 Angiopoietin-related protein 3 Proteins 0.000 description 1
102100030988 Angiotensin-converting enzyme Human genes 0.000 description 1
102000004881 Angiotensinogen Human genes 0.000 description 1
108090001067 Angiotensinogen Proteins 0.000 description 1
102000004145 Annexin A1 Human genes 0.000 description 1
108090000663 Annexin A1 Proteins 0.000 description 1
102000016555 Apelin receptors Human genes 0.000 description 1
101710095342 Apolipoprotein B Proteins 0.000 description 1
102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
102000018757 Apolipoprotein L1 Human genes 0.000 description 1
108010052469 Apolipoprotein L1 Proteins 0.000 description 1
108010071619 Apolipoproteins Proteins 0.000 description 1
102000007592 Apolipoproteins Human genes 0.000 description 1
101710124361 Arylamine N-acetyltransferase 2 Proteins 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
102100022718 Atypical chemokine receptor 2 Human genes 0.000 description 1
102100038080 B-cell receptor CD22 Human genes 0.000 description 1
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
101710117995 B-lymphocyte antigen CD19 Proteins 0.000 description 1
108091005625 BRD4 Proteins 0.000 description 1
229940124291 BTK inhibitor Drugs 0.000 description 1
101000963440 Bacillus subtilis (strain 168) Biotin carboxylase 1 Proteins 0.000 description 1
101000782621 Bacillus subtilis (strain 168) Biotin carboxylase 2 Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
102100032412 Basigin Human genes 0.000 description 1
108010064528 Basigin Proteins 0.000 description 1
229940123606 Bcl-w inhibitor Drugs 0.000 description 1
229940122226 Benzodiazepine receptor agonist Drugs 0.000 description 1
229940123768 Beta amyloid protein antagonist Drugs 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
102100020683 Beta-klotho Human genes 0.000 description 1
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 1
101000645291 Bos taurus Metalloproteinase inhibitor 2 Proteins 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
102000010183 Bradykinin receptor Human genes 0.000 description 1
108050001736 Bradykinin receptor Proteins 0.000 description 1
102100026437 Branched-chain-amino-acid aminotransferase, cytosolic Human genes 0.000 description 1
101710142286 Branched-chain-amino-acid transaminase 1 Proteins 0.000 description 1
102100033640 Bromodomain-containing protein 1 Human genes 0.000 description 1
102100033641 Bromodomain-containing protein 2 Human genes 0.000 description 1
102100029895 Bromodomain-containing protein 4 Human genes 0.000 description 1
VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
102100031151 C-C chemokine receptor type 2 Human genes 0.000 description 1
101710149815 C-C chemokine receptor type 2 Proteins 0.000 description 1
102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 1
101710149862 C-C chemokine receptor type 3 Proteins 0.000 description 1
101710149863 C-C chemokine receptor type 4 Proteins 0.000 description 1
102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 1
102100025074 C-C chemokine receptor-like 2 Human genes 0.000 description 1
102100036849 C-C motif chemokine 24 Human genes 0.000 description 1
108090000342 C-Type Lectins Proteins 0.000 description 1
102000003930 C-Type Lectins Human genes 0.000 description 1
102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 description 1
102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
VYLJAYXZTOTZRR-BTPDVQIOSA-N CC(C)(O)[C@H]1CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2CC[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3[C@@H](O)[C@H](O)[C@@]12C Chemical compound CC(C)(O)[C@H]1CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2CC[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3[C@@H](O)[C@H](O)[C@@]12C VYLJAYXZTOTZRR-BTPDVQIOSA-N 0.000 description 1
108010064535 CCAAT-Enhancer-Binding Protein-beta Proteins 0.000 description 1
102100034798 CCAAT/enhancer-binding protein beta Human genes 0.000 description 1
229940122623 CCK receptor antagonist Drugs 0.000 description 1
102100031168 CCN family member 2 Human genes 0.000 description 1
102100031170 CCN family member 3 Human genes 0.000 description 1
101710137351 CCN family member 3 Proteins 0.000 description 1
101150019010 CCR3 gene Proteins 0.000 description 1
102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 description 1
229940119510 CD11b agonist Drugs 0.000 description 1
229940124159 CD39 agonist Drugs 0.000 description 1
108010029697 CD40 Ligand Proteins 0.000 description 1
102100032937 CD40 ligand Human genes 0.000 description 1
229940122004 CD47 antagonist Drugs 0.000 description 1
229940124111 CD52 antagonist Drugs 0.000 description 1
101150063947 CHST15 gene Proteins 0.000 description 1
108010040163 CREB-Binding Protein Proteins 0.000 description 1
102100021975 CREB-binding protein Human genes 0.000 description 1
108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 1
102100039196 CX3C chemokine receptor 1 Human genes 0.000 description 1
229940124803 CXCR2 antagonist Drugs 0.000 description 1
108060001064 Calcitonin Proteins 0.000 description 1
102000055006 Calcitonin Human genes 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
108090000312 Calcium Channels Proteins 0.000 description 1
102000003922 Calcium Channels Human genes 0.000 description 1
102100029968 Calreticulin Human genes 0.000 description 1
108090000549 Calreticulin Proteins 0.000 description 1
229940123158 Cannabinoid CB1 receptor antagonist Drugs 0.000 description 1
229940123368 Cannabinoid CB2 receptor agonist Drugs 0.000 description 1
102100033868 Cannabinoid receptor 1 Human genes 0.000 description 1
229940122820 Cannabinoid receptor antagonist Drugs 0.000 description 1
241000283707 Capra Species 0.000 description 1
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
229940122072 Carbonic anhydrase inhibitor Drugs 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
108010047048 Casein Kinase Idelta Proteins 0.000 description 1
108090000397 Caspase 3 Proteins 0.000 description 1
229940123169 Caspase inhibitor Drugs 0.000 description 1
102100029855 Caspase-3 Human genes 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
229940122156 Cathepsin K inhibitor Drugs 0.000 description 1
229940122805 Cathepsin S inhibitor Drugs 0.000 description 1
229940123003 Cathepsin inhibitor Drugs 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
102100021396 Cell surface glycoprotein CD200 receptor 1 Human genes 0.000 description 1
102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 description 1
101710144787 Cell surface glycoprotein MUC18 Proteins 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
108091006146 Channels Proteins 0.000 description 1
108050001186 Chaperonin Cpn60 Proteins 0.000 description 1
102000052603 Chaperonins Human genes 0.000 description 1
108010083647 Chemokine CCL24 Proteins 0.000 description 1
108010078239 Chemokine CX3CL1 Proteins 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
108010018888 Choline kinase Proteins 0.000 description 1
102100031065 Choline kinase alpha Human genes 0.000 description 1
108090000746 Chymosin Proteins 0.000 description 1
102100040836 Claudin-1 Human genes 0.000 description 1
108090000600 Claudin-1 Proteins 0.000 description 1
102000003780 Clusterin Human genes 0.000 description 1
108090000197 Clusterin Proteins 0.000 description 1
101000573945 Coccidioides posadasii (strain C735) Neutral protease 2 homolog MEP2 Proteins 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
102100031162 Collagen alpha-1(XVIII) chain Human genes 0.000 description 1
229940122097 Collagenase inhibitor Drugs 0.000 description 1
102000014447 Complement C1q Human genes 0.000 description 1
108010078043 Complement C1q Proteins 0.000 description 1
102100025406 Complement C1s subcomponent Human genes 0.000 description 1
108050005572 Complement C1s subcomponent Proteins 0.000 description 1
108010028773 Complement C5 Proteins 0.000 description 1
102100031506 Complement C5 Human genes 0.000 description 1
108010078546 Complement C5a Proteins 0.000 description 1
229940122127 Complement factor B inhibitor Drugs 0.000 description 1
229940076722 Complement factor D inhibitor Drugs 0.000 description 1
108010039419 Connective Tissue Growth Factor Proteins 0.000 description 1
102000008954 Copper amine oxidases Human genes 0.000 description 1
102100027587 Copper-transporting ATPase 1 Human genes 0.000 description 1
108010074311 Corticotropin Receptors Proteins 0.000 description 1
MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
229920002785 Croscarmellose sodium Polymers 0.000 description 1
102100031256 Cyclic GMP-AMP synthase Human genes 0.000 description 1
108010009911 Cytochrome P-450 CYP11B2 Proteins 0.000 description 1
102100038637 Cytochrome P450 7A1 Human genes 0.000 description 1
101710176143 Cytochrome P450 7A1 Proteins 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
229940127194 DGAT2 inhibitor Drugs 0.000 description 1
229940127399 DNA Polymerase Inhibitors Drugs 0.000 description 1
229940124087 DNA topoisomerase II inhibitor Drugs 0.000 description 1
102100037799 DNA-binding protein Ikaros Human genes 0.000 description 1
101710143811 DNA-binding protein Ikaros Proteins 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
JVHXJTBJCFBINQ-ADAARDCZSA-N Dapagliflozin Chemical compound C1=CC(OCC)=CC=C1CC1=CC([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC=C1Cl JVHXJTBJCFBINQ-ADAARDCZSA-N 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
102100030012 Deoxyribonuclease-1 Human genes 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
101150102653 Dgat2 gene Proteins 0.000 description 1
208000007342 Diabetic Nephropathies Diseases 0.000 description 1
102100035762 Diacylglycerol O-acyltransferase 2 Human genes 0.000 description 1
235000019739 Dicalciumphosphate Nutrition 0.000 description 1
102100024746 Dihydrofolate reductase Human genes 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 description 1
102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 1
102000004073 Dopamine D3 Receptors Human genes 0.000 description 1
108090000525 Dopamine D3 Receptors Proteins 0.000 description 1
102000003962 Dopamine D4 receptors Human genes 0.000 description 1
108090000357 Dopamine D4 receptors Proteins 0.000 description 1
102100023266 Dual specificity mitogen-activated protein kinase kinase 2 Human genes 0.000 description 1
101710146529 Dual specificity mitogen-activated protein kinase kinase 2 Proteins 0.000 description 1
102000017914 EDNRA Human genes 0.000 description 1
101150062404 EDNRA gene Proteins 0.000 description 1
102000017930 EDNRB Human genes 0.000 description 1
101150001833 EDNRB gene Proteins 0.000 description 1
101150114117 EGR1 gene Proteins 0.000 description 1
102100021977 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Human genes 0.000 description 1
108050004000 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Proteins 0.000 description 1
102100031334 Elongation factor 2 Human genes 0.000 description 1
102100037241 Endoglin Human genes 0.000 description 1
108010036395 Endoglin Proteins 0.000 description 1
102100039328 Endoplasmin Human genes 0.000 description 1
102100030013 Endoribonuclease Human genes 0.000 description 1
102100038083 Endosialin Human genes 0.000 description 1
101710144543 Endosialin Proteins 0.000 description 1
108010079505 Endostatins Proteins 0.000 description 1
101710184673 Enolase 1 Proteins 0.000 description 1
102100029727 Enteropeptidase Human genes 0.000 description 1
108010013369 Enteropeptidase Proteins 0.000 description 1
102400001368 Epidermal growth factor Human genes 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
229940127514 Epoxide Hydrolase Inhibitors Drugs 0.000 description 1
229940122580 Erythropoietin receptor antagonist Drugs 0.000 description 1
208000006168 Ewing Sarcoma Diseases 0.000 description 1
HTQBXNHDCUEHJF-XWLPCZSASA-N Exenatide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 1
108010011459 Exenatide Proteins 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
108010004078 F1F0-ATP synthase Proteins 0.000 description 1
101150051399 FGF19 gene Proteins 0.000 description 1
108010029144 Factor IIa Proteins 0.000 description 1
108010071241 Factor XIIa Proteins 0.000 description 1
108010039731 Fatty Acid Synthases Proteins 0.000 description 1
108010087819 Fc receptors Proteins 0.000 description 1
102000009109 Fc receptors Human genes 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
MBMLMWLHJBBADN-UHFFFAOYSA-N Ferrous sulfide Chemical compound [Fe]=S MBMLMWLHJBBADN-UHFFFAOYSA-N 0.000 description 1
102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
102100031734 Fibroblast growth factor 19 Human genes 0.000 description 1
102000003973 Fibroblast growth factor 21 Human genes 0.000 description 1
108090000376 Fibroblast growth factor 21 Proteins 0.000 description 1
102100028043 Fibroblast growth factor 3 Human genes 0.000 description 1
UUOUOERPONYGOS-CLCRDYEYSA-N Fluocinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3C[C@H](F)C2=C1 UUOUOERPONYGOS-CLCRDYEYSA-N 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
102000010449 Folate receptor beta Human genes 0.000 description 1
108050001930 Folate receptor beta Proteins 0.000 description 1
102100020997 Fractalkine Human genes 0.000 description 1
101710142060 Free fatty acid receptor 1 Proteins 0.000 description 1
102100040133 Free fatty acid receptor 2 Human genes 0.000 description 1
101710142059 Free fatty acid receptor 2 Proteins 0.000 description 1
229940121703 Free fatty acid receptor 2 antagonist Drugs 0.000 description 1
241000233866 Fungi Species 0.000 description 1
102100025353 G-protein coupled bile acid receptor 1 Human genes 0.000 description 1
101710154531 G-protein coupled bile acid receptor 1 Proteins 0.000 description 1
102100023416 G-protein coupled receptor 15 Human genes 0.000 description 1
101710108136 G-protein coupled receptor 15 Proteins 0.000 description 1
102100033864 G-protein coupled receptor 84 Human genes 0.000 description 1
101150037782 GAL2 gene Proteins 0.000 description 1
102000004610 GATA3 Transcription Factor Human genes 0.000 description 1
108010003338 GATA3 Transcription Factor Proteins 0.000 description 1
102100040304 GDNF family receptor alpha-like Human genes 0.000 description 1
101710174136 GDNF family receptor alpha-like Proteins 0.000 description 1
101150020003 GHR gene Proteins 0.000 description 1
108090000926 GMP synthase (glutamine-hydrolyzing) Proteins 0.000 description 1
102100033452 GMP synthase [glutamine-hydrolyzing] Human genes 0.000 description 1
229940125633 GPCR agonist Drugs 0.000 description 1
102000000312 GTP-Binding Protein beta Subunits Human genes 0.000 description 1
108010080615 GTP-Binding Protein beta Subunits Proteins 0.000 description 1
102400001370 Galanin Human genes 0.000 description 1
101800002068 Galanin Proteins 0.000 description 1
102100021735 Galectin-2 Human genes 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
102400000321 Glucagon Human genes 0.000 description 1
108060003199 Glucagon Proteins 0.000 description 1
102100040890 Glucagon receptor Human genes 0.000 description 1
102400000322 Glucagon-like peptide 1 Human genes 0.000 description 1
101800000224 Glucagon-like peptide 1 Proteins 0.000 description 1
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 1
229940089838 Glucagon-like peptide 1 receptor agonist Drugs 0.000 description 1
101800000221 Glucagon-like peptide 2 Proteins 0.000 description 1
108010021582 Glucokinase Proteins 0.000 description 1
102000030595 Glucokinase Human genes 0.000 description 1
229940123454 Glucose transporter 1 inhibitor Drugs 0.000 description 1
102100035172 Glucose-6-phosphate 1-dehydrogenase Human genes 0.000 description 1
101710155861 Glucose-6-phosphate 1-dehydrogenase Proteins 0.000 description 1
102000017278 Glutaredoxin Human genes 0.000 description 1
108050005205 Glutaredoxin Proteins 0.000 description 1
244000060234 Gmelina philippensis Species 0.000 description 1
102100033851 Gonadotropin-releasing hormone receptor Human genes 0.000 description 1
108010092372 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Proteins 0.000 description 1
102000016355 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Human genes 0.000 description 1
102000009465 Growth Factor Receptors Human genes 0.000 description 1
108010009202 Growth Factor Receptors Proteins 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
229940127461 Growth Hormone Receptor Agonists Drugs 0.000 description 1
229940123011 Growth factor receptor antagonist Drugs 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
102100025255 Haptoglobin Human genes 0.000 description 1
102000002812 Heat-Shock Proteins Human genes 0.000 description 1
108010004889 Heat-Shock Proteins Proteins 0.000 description 1
101710082112 Hematopoietic prostaglandin D synthase Proteins 0.000 description 1
241000711549 Hepacivirus C Species 0.000 description 1
108090000100 Hepatocyte Growth Factor Proteins 0.000 description 1
108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 description 1
108010061414 Hepatocyte Nuclear Factor 1-beta Proteins 0.000 description 1
108010086524 Hepatocyte Nuclear Factor 4 Proteins 0.000 description 1
102100021866 Hepatocyte growth factor Human genes 0.000 description 1
102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 1
102100022123 Hepatocyte nuclear factor 1-beta Human genes 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
102100037907 High mobility group protein B1 Human genes 0.000 description 1
101710168537 High mobility group protein B1 Proteins 0.000 description 1
229940124056 Histamine H1 receptor antagonist Drugs 0.000 description 1
229940119240 Histamine H4 receptor antagonist Drugs 0.000 description 1
102100032742 Histone-lysine N-methyltransferase SETD2 Human genes 0.000 description 1
102000009331 Homeodomain Proteins Human genes 0.000 description 1
108010048671 Homeodomain Proteins Proteins 0.000 description 1
102100032827 Homeodomain-interacting protein kinase 2 Human genes 0.000 description 1
101001045211 Homo sapiens 17-beta-hydroxysteroid dehydrogenase type 3 Proteins 0.000 description 1
101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
101000959452 Homo sapiens Alcohol dehydrogenase class-3 Proteins 0.000 description 1
101000924488 Homo sapiens Atrial natriuretic peptide receptor 3 Proteins 0.000 description 1
101000678892 Homo sapiens Atypical chemokine receptor 2 Proteins 0.000 description 1
101001139095 Homo sapiens Beta-klotho Proteins 0.000 description 1
101000871846 Homo sapiens Bromodomain-containing protein 1 Proteins 0.000 description 1
101000871850 Homo sapiens Bromodomain-containing protein 2 Proteins 0.000 description 1
101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 1
101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 1
101000716070 Homo sapiens C-C chemokine receptor type 9 Proteins 0.000 description 1
101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 description 1
101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 description 1
101100382566 Homo sapiens CASP9 gene Proteins 0.000 description 1
101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 1
101000710899 Homo sapiens Cannabinoid receptor 1 Proteins 0.000 description 1
101000969553 Homo sapiens Cell surface glycoprotein CD200 receptor 1 Proteins 0.000 description 1
101000776648 Homo sapiens Cyclic GMP-AMP synthase Proteins 0.000 description 1
101000930020 Homo sapiens Diacylglycerol O-acyltransferase 2 Proteins 0.000 description 1
101001010783 Homo sapiens Endoribonuclease Proteins 0.000 description 1
101000846394 Homo sapiens Fibroblast growth factor 19 Proteins 0.000 description 1
101001060280 Homo sapiens Fibroblast growth factor 3 Proteins 0.000 description 1
101000912510 Homo sapiens Free fatty acid receptor 1 Proteins 0.000 description 1
101001069589 Homo sapiens G-protein coupled receptor 84 Proteins 0.000 description 1
101001040075 Homo sapiens Glucagon receptor Proteins 0.000 description 1
101000988802 Homo sapiens Hematopoietic prostaglandin D synthase Proteins 0.000 description 1
101000654725 Homo sapiens Histone-lysine N-methyltransferase SETD2 Proteins 0.000 description 1
101001066401 Homo sapiens Homeodomain-interacting protein kinase 2 Proteins 0.000 description 1
101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 description 1
101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
101001054334 Homo sapiens Interferon beta Proteins 0.000 description 1
101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 description 1
101000998146 Homo sapiens Interleukin-17A Proteins 0.000 description 1
101000998181 Homo sapiens Interleukin-17B Proteins 0.000 description 1
101000852980 Homo sapiens Interleukin-23 subunit alpha Proteins 0.000 description 1
101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
101100236405 Homo sapiens MAP3K2 gene Proteins 0.000 description 1
101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
101001055091 Homo sapiens Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 1
101000623897 Homo sapiens Mucin-12 Proteins 0.000 description 1
101000844245 Homo sapiens Non-receptor tyrosine-protein kinase TYK2 Proteins 0.000 description 1
101100244213 Homo sapiens PNPLA3 gene Proteins 0.000 description 1
101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 1
101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
101001051777 Homo sapiens Protein kinase C alpha type Proteins 0.000 description 1
101001116937 Homo sapiens Protocadherin alpha-4 Proteins 0.000 description 1
101001109137 Homo sapiens Receptor-interacting serine/threonine-protein kinase 2 Proteins 0.000 description 1
101000628693 Homo sapiens Serine/threonine-protein kinase 25 Proteins 0.000 description 1
101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
101000709250 Homo sapiens Serine/threonine-protein kinase SIK2 Proteins 0.000 description 1
101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
101000952234 Homo sapiens Sphingolipid delta(4)-desaturase DES1 Proteins 0.000 description 1
101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
101000596277 Homo sapiens TSC22 domain family protein 3 Proteins 0.000 description 1
101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
101000830603 Homo sapiens Tumor necrosis factor ligand superfamily member 11 Proteins 0.000 description 1
101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
101000599042 Homo sapiens Zinc finger protein Aiolos Proteins 0.000 description 1
229940123486 Hormone receptor agonist Drugs 0.000 description 1
101150000579 Hsd17b13 gene Proteins 0.000 description 1
241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102000001974 Hyaluronidases Human genes 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 description 1
239000003458 I kappa b kinase inhibitor Substances 0.000 description 1
101150050263 ICAM1 gene Proteins 0.000 description 1
229940124753 IL-2 agonist Drugs 0.000 description 1
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
102000016844 Immunoglobulin-like domains Human genes 0.000 description 1
108050006430 Immunoglobulin-like domains Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
102100021854 Inhibitor of nuclear factor kappa-B kinase subunit beta Human genes 0.000 description 1
101710205525 Inhibitor of nuclear factor kappa-B kinase subunit beta Proteins 0.000 description 1
108030003815 Inositol 3-kinases Proteins 0.000 description 1
102000003746 Insulin Receptor Human genes 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
229940127519 Insulin Receptor Agonists Drugs 0.000 description 1
229940122355 Insulin sensitizer Drugs 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
102100025323 Integrin alpha-1 Human genes 0.000 description 1
102100039903 Integrin alpha-9 Human genes 0.000 description 1
108010041341 Integrin alpha1 Proteins 0.000 description 1
102100025304 Integrin beta-1 Human genes 0.000 description 1
102100033011 Integrin beta-6 Human genes 0.000 description 1
102100033016 Integrin beta-7 Human genes 0.000 description 1
102100033336 Integrin beta-8 Human genes 0.000 description 1
102000008607 Integrin beta3 Human genes 0.000 description 1
108010020950 Integrin beta3 Proteins 0.000 description 1
102100026720 Interferon beta Human genes 0.000 description 1
102100035678 Interferon gamma receptor 1 Human genes 0.000 description 1
102000003996 Interferon-beta Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
102100020881 Interleukin-1 alpha Human genes 0.000 description 1
102000019223 Interleukin-1 receptor Human genes 0.000 description 1
108050006617 Interleukin-1 receptor Proteins 0.000 description 1
102100039880 Interleukin-1 receptor accessory protein Human genes 0.000 description 1
101710180389 Interleukin-1 receptor accessory protein Proteins 0.000 description 1
102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 1
108700021006 Interleukin-1 receptor antagonist Proteins 0.000 description 1
102000003815 Interleukin-11 Human genes 0.000 description 1
108090000177 Interleukin-11 Proteins 0.000 description 1
108010065805 Interleukin-12 Proteins 0.000 description 1
108090000172 Interleukin-15 Proteins 0.000 description 1
102100033461 Interleukin-17A Human genes 0.000 description 1
102100033101 Interleukin-17B Human genes 0.000 description 1
102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 description 1
101710138729 Interleukin-18 receptor accessory protein Proteins 0.000 description 1
108010082786 Interleukin-1alpha Proteins 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
108010065637 Interleukin-23 Proteins 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
108010067003 Interleukin-33 Proteins 0.000 description 1
108091007973 Interleukin-36 Proteins 0.000 description 1
108010002616 Interleukin-5 Proteins 0.000 description 1
108010038501 Interleukin-6 Receptors Proteins 0.000 description 1
102000010781 Interleukin-6 Receptors Human genes 0.000 description 1
102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 1
102000010782 Interleukin-7 Receptors Human genes 0.000 description 1
108010038498 Interleukin-7 Receptors Proteins 0.000 description 1
108010033149 Intermediate-Conductance Calcium-Activated Potassium Channels Proteins 0.000 description 1
102000007008 Intermediate-Conductance Calcium-Activated Potassium Channels Human genes 0.000 description 1
102000005298 Iron-Sulfur Proteins Human genes 0.000 description 1
108010081409 Iron-Sulfur Proteins Proteins 0.000 description 1
101150069380 JAK3 gene Proteins 0.000 description 1
108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 1
229940116839 Janus kinase 1 inhibitor Drugs 0.000 description 1
229940121730 Janus kinase 2 inhibitor Drugs 0.000 description 1
229940123241 Janus kinase 3 inhibitor Drugs 0.000 description 1
101150088123 KCNN4 gene Proteins 0.000 description 1
102100021559 KRR1 small subunit processome component homolog Human genes 0.000 description 1
229940127379 Kallikrein Inhibitors Drugs 0.000 description 1
102100038356 Kallikrein-2 Human genes 0.000 description 1
101710176220 Kallikrein-2 Proteins 0.000 description 1
102100034867 Kallikrein-7 Human genes 0.000 description 1
101710176222 Kallikrein-7 Proteins 0.000 description 1
102100026388 L-amino-acid oxidase Human genes 0.000 description 1
239000002144 L01XE18 - Ruxolitinib Substances 0.000 description 1
108010021290 LHRH Receptors Proteins 0.000 description 1
108010063045 Lactoferrin Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
102100032241 Lactotransferrin Human genes 0.000 description 1
102100022118 Leukotriene A-4 hydrolase Human genes 0.000 description 1
102000003680 Leukotriene B4 receptors Human genes 0.000 description 1
108090000093 Leukotriene B4 receptors Proteins 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
LTXREWYXXSTFRX-QGZVFWFLSA-N Linagliptin Chemical compound N=1C=2N(C)C(=O)N(CC=3N=C4C=CC=CC4=C(C)N=3)C(=O)C=2N(CC#CC)C=1N1CCC[C@@H](N)C1 LTXREWYXXSTFRX-QGZVFWFLSA-N 0.000 description 1
229940127470 Lipase Inhibitors Drugs 0.000 description 1
108010013563 Lipoprotein Lipase Proteins 0.000 description 1
102100022119 Lipoprotein lipase Human genes 0.000 description 1
239000000867 Lipoxygenase Inhibitor Substances 0.000 description 1
102000003820 Lipoxygenases Human genes 0.000 description 1
108090000128 Lipoxygenases Proteins 0.000 description 1
YSDQQAXHVYUZIW-QCIJIYAXSA-N Liraglutide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 YSDQQAXHVYUZIW-QCIJIYAXSA-N 0.000 description 1
108010019598 Liraglutide Proteins 0.000 description 1
XVVOERDUTLJJHN-UHFFFAOYSA-N Lixisenatide Chemical compound C=1NC2=CC=CC=C2C=1CC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(N)=O)C(=O)NCC(=O)NCC(=O)N1C(CCC1)C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N1C(CCC1)C(=O)N1C(CCC1)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)CC)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(CCC(O)=O)NC(=O)C(CCC(O)=O)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC=1C=CC=CC=1)NC(=O)C(NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)CNC(=O)C(N)CC=1NC=NC=1)C(C)O)C(C)O)C(C)C)CC1=CC=CC=C1 XVVOERDUTLJJHN-UHFFFAOYSA-N 0.000 description 1
108010015340 Low Density Lipoprotein Receptor-Related Protein-1 Proteins 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
102000002576 MAP Kinase Kinase 1 Human genes 0.000 description 1
108010068342 MAP Kinase Kinase 1 Proteins 0.000 description 1
102000043136 MAP kinase family Human genes 0.000 description 1
108091054455 MAP kinase family Proteins 0.000 description 1
102100034069 MAP kinase-activated protein kinase 2 Human genes 0.000 description 1
102100028396 MAP kinase-activated protein kinase 5 Human genes 0.000 description 1
108010041955 MAP-kinase-activated kinase 2 Proteins 0.000 description 1
108010041164 MAP-kinase-activated kinase 5 Proteins 0.000 description 1
101150022772 MAP3K2 gene Proteins 0.000 description 1
108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 description 1
102100025354 Macrophage mannose receptor 1 Human genes 0.000 description 1
101710124692 Macrophage mannose receptor 1 Proteins 0.000 description 1
102100037791 Macrophage migration inhibitory factor Human genes 0.000 description 1
102100026046 Mannan-binding lectin serine protease 2 Human genes 0.000 description 1
101710117460 Mannan-binding lectin serine protease 2 Proteins 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
108010087870 Mannose-Binding Lectin Proteins 0.000 description 1
102000009112 Mannose-Binding Lectin Human genes 0.000 description 1
101150010110 Map3k8 gene Proteins 0.000 description 1
102100026142 Matrix extracellular phosphoglycoprotein Human genes 0.000 description 1
101710184030 Matrix extracellular phosphoglycoprotein Proteins 0.000 description 1
101150106280 Mchr1 gene Proteins 0.000 description 1
102100027375 Melanin-concentrating hormone receptor 1 Human genes 0.000 description 1
108700036626 Melanin-concentrating hormone receptor 1 Proteins 0.000 description 1
229940124250 Melanocortin MC-1 receptor agonist Drugs 0.000 description 1
229940122271 Melanocortin MC-3 receptor agonist Drugs 0.000 description 1
229940117029 Melanocortin receptor agonist Drugs 0.000 description 1
102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
229940084845 Metalloproteinase-1 inhibitor Drugs 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
229940122028 Methionine aminopeptidase-2 inhibitor Drugs 0.000 description 1
102000006890 Methyl-CpG-Binding Protein 2 Human genes 0.000 description 1
108010072388 Methyl-CpG-Binding Protein 2 Proteins 0.000 description 1
108091028080 MiR-132 Proteins 0.000 description 1
IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 description 1
108010050258 Mitochondrial Uncoupling Proteins Proteins 0.000 description 1
102000015494 Mitochondrial Uncoupling Proteins Human genes 0.000 description 1
101710151803 Mitochondrial intermediate peptidase 2 Proteins 0.000 description 1
102100025031 Mitochondrial pyruvate carrier 2 Human genes 0.000 description 1
229940121875 Mitochondrial pyruvate carrier inhibitor Drugs 0.000 description 1
108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 description 1
102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 description 1
102100024189 Mitogen-activated protein kinase 4 Human genes 0.000 description 1
101710166114 Mitogen-activated protein kinase 4 Proteins 0.000 description 1
102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 1
101710164337 Mitogen-activated protein kinase kinase kinase 5 Proteins 0.000 description 1
HZQDCMWJEBCWBR-UUOKFMHZSA-N Mizoribine Chemical compound OC1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 HZQDCMWJEBCWBR-UUOKFMHZSA-N 0.000 description 1
102000017298 Monocarboxylate transporters Human genes 0.000 description 1
108050005244 Monocarboxylate transporters Proteins 0.000 description 1
102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
102100023143 Mucin-12 Human genes 0.000 description 1
101000878182 Mus musculus Fibroblast growth factor 15 Proteins 0.000 description 1
101100335081 Mus musculus Flt3 gene Proteins 0.000 description 1
101001065566 Mus musculus Lymphocyte antigen 6A-2/6E-1 Proteins 0.000 description 1
101100268066 Mus musculus Zap70 gene Proteins 0.000 description 1
RTGDFNSFWBGLEC-UHFFFAOYSA-N Mycophenolate mofetil Chemical compound COC1=C(C)C=2COC(=O)C=2C(O)=C1CC=C(C)CCC(=O)OCCN1CCOCC1 RTGDFNSFWBGLEC-UHFFFAOYSA-N 0.000 description 1
108010083674 Myelin Proteins Proteins 0.000 description 1
102000006386 Myelin Proteins Human genes 0.000 description 1
102100034681 Myeloblastin Human genes 0.000 description 1
108090000973 Myeloblastin Proteins 0.000 description 1
229940122159 Myeloperoxidase inhibitor Drugs 0.000 description 1
102100038303 Myosin-2 Human genes 0.000 description 1
101710204037 Myosin-2 Proteins 0.000 description 1
102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
102100031455 NAD-dependent protein deacetylase sirtuin-1 Human genes 0.000 description 1
229940122554 NADPH oxidase 1 inhibitor Drugs 0.000 description 1
229940123676 NADPH oxidase 4 inhibitor Drugs 0.000 description 1
229940123857 NADPH oxidase inhibitor Drugs 0.000 description 1
108010045510 NADPH-Ferrihemoprotein Reductase Proteins 0.000 description 1
101150086808 NAMPT gene Proteins 0.000 description 1
108010057466 NF-kappa B Proteins 0.000 description 1
102000003945 NF-kappa B Human genes 0.000 description 1
108091008877 NK cell receptors Proteins 0.000 description 1
102100022697 NLR family member X1 Human genes 0.000 description 1
101710129833 NLR family member X1 Proteins 0.000 description 1
101150112455 NOX4 gene Proteins 0.000 description 1
102000002452 NPR3 Human genes 0.000 description 1
BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
102100021462 Natural killer cells antigen CD94 Human genes 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
206010061309 Neoplasm progression Diseases 0.000 description 1
102100023195 Nephrin Human genes 0.000 description 1
108010040718 Neurokinin-1 Receptors Proteins 0.000 description 1
102100028492 Neuropilin-2 Human genes 0.000 description 1
108090000770 Neuropilin-2 Proteins 0.000 description 1
229940119372 Niacin receptor 1 agonist Drugs 0.000 description 1
229940093130 Niacinamide phosphoribosyltransferase inhibitor Drugs 0.000 description 1
102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 1
108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 1
108010075520 Nitric Oxide Synthase Type III Proteins 0.000 description 1
102100028452 Nitric oxide synthase, endothelial Human genes 0.000 description 1
102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 1
101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 1
101150083031 Nod2 gene Proteins 0.000 description 1
108010032107 Non-Receptor Type 11 Protein Tyrosine Phosphatase Proteins 0.000 description 1
108010032073 Non-Receptor Type 13 Protein Tyrosine Phosphatase Proteins 0.000 description 1
102100032028 Non-receptor tyrosine-protein kinase TYK2 Human genes 0.000 description 1
101800001014 Non-structural protein 5A Proteins 0.000 description 1
102000003789 Nuclear pore complex proteins Human genes 0.000 description 1
108090000163 Nuclear pore complex proteins Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
229940122313 Nucleoside reverse transcriptase inhibitor Drugs 0.000 description 1
102100022396 Nucleosome assembly protein 1-like 4 Human genes 0.000 description 1
101710192965 Nucleosome assembly protein 1-like 4 Proteins 0.000 description 1
102000004473 OX40 Ligand Human genes 0.000 description 1
108010042215 OX40 Ligand Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
102000004020 Oxygenases Human genes 0.000 description 1
108090000417 Oxygenases Proteins 0.000 description 1
102400000319 Oxyntomodulin Human genes 0.000 description 1
101800001388 Oxyntomodulin Proteins 0.000 description 1
102100040460 P2X purinoceptor 3 Human genes 0.000 description 1
101710189970 P2X purinoceptor 3 Proteins 0.000 description 1
102100037602 P2X purinoceptor 7 Human genes 0.000 description 1
101710189965 P2X purinoceptor 7 Proteins 0.000 description 1
102100026168 P2Y purinoceptor 13 Human genes 0.000 description 1
101710192337 P2Y purinoceptor 13 Proteins 0.000 description 1
102100028074 P2Y purinoceptor 6 Human genes 0.000 description 1
101710096702 P2Y purinoceptor 6 Proteins 0.000 description 1
108091008010 PERKs Proteins 0.000 description 1
102000023984 PPAR alpha Human genes 0.000 description 1
108010015181 PPAR delta Proteins 0.000 description 1
108010016731 PPAR gamma Proteins 0.000 description 1
102000000536 PPAR gamma Human genes 0.000 description 1
101150004011 PRKAA2 gene Proteins 0.000 description 1
101150000187 PTGS2 gene Proteins 0.000 description 1
102000003982 Parathyroid hormone Human genes 0.000 description 1
108090000445 Parathyroid hormone Proteins 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
108010077519 Peptide Elongation Factor 2 Proteins 0.000 description 1
108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
102100040349 Peptidyl-prolyl cis-trans isomerase FKBP10 Human genes 0.000 description 1
101710111764 Peptidyl-prolyl cis-trans isomerase FKBP10 Proteins 0.000 description 1
102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 1
108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
229940049937 Pgp inhibitor Drugs 0.000 description 1
108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 1
102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 1
102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 description 1
229940121836 Phosphodiesterase 1 inhibitor Drugs 0.000 description 1
229940121828 Phosphodiesterase 2 inhibitor Drugs 0.000 description 1
229940123263 Phosphodiesterase 3 inhibitor Drugs 0.000 description 1
229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 description 1
229940123333 Phosphodiesterase 5 inhibitor Drugs 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
102000009097 Phosphorylases Human genes 0.000 description 1
108010073135 Phosphorylases Proteins 0.000 description 1
102100034309 Pituitary adenylate cyclase-activating polypeptide type I receptor Human genes 0.000 description 1
108010035030 Platelet Membrane Glycoprotein IIb Proteins 0.000 description 1
108700023400 Platelet-activating factor receptors Proteins 0.000 description 1
102000002099 Plexin domain-containing proteins Human genes 0.000 description 1
108050009435 Plexin domain-containing proteins Proteins 0.000 description 1
RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
102000004257 Potassium Channel Human genes 0.000 description 1
102100026126 Proline-tRNA ligase Human genes 0.000 description 1
101710115782 Proline-tRNA ligase Proteins 0.000 description 1
102100021923 Prolow-density lipoprotein receptor-related protein 1 Human genes 0.000 description 1
108010043005 Prolyl Hydroxylases Proteins 0.000 description 1
102000004079 Prolyl Hydroxylases Human genes 0.000 description 1
102000006437 Proprotein Convertases Human genes 0.000 description 1
108010044159 Proprotein Convertases Proteins 0.000 description 1
229940127473 Prostaglandin Receptor Agonists Drugs 0.000 description 1
108030003866 Prostaglandin-D synthases Proteins 0.000 description 1
102000048176 Prostaglandin-D synthases Human genes 0.000 description 1
239000004365 Protease Substances 0.000 description 1
229940118430 Protease-activated receptor-2 antagonist Drugs 0.000 description 1
108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
229940079156 Proteasome inhibitor Drugs 0.000 description 1
101800004937 Protein C Proteins 0.000 description 1
108091008611 Protein Kinase B Proteins 0.000 description 1
101710150344 Protein Rev Proteins 0.000 description 1
102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
102100032783 Protein cereblon Human genes 0.000 description 1
101710086076 Protein cereblon Proteins 0.000 description 1
101710092489 Protein kinase 2 Proteins 0.000 description 1
102100024924 Protein kinase C alpha type Human genes 0.000 description 1
108010090931 Proto-Oncogene Proteins c-bcl-2 Proteins 0.000 description 1
102000013535 Proto-Oncogene Proteins c-bcl-2 Human genes 0.000 description 1
108010072960 Proto-Oncogene Proteins c-fyn Proteins 0.000 description 1
102000007131 Proto-Oncogene Proteins c-fyn Human genes 0.000 description 1
102000000033 Purinergic Receptors Human genes 0.000 description 1
108010080192 Purinergic Receptors Proteins 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 1
101150040459 RAS gene Proteins 0.000 description 1
101000912235 Rebecca salina Acyl-lipid (7-3)-desaturase Proteins 0.000 description 1
101710138589 Receptor-interacting serine/threonine-protein kinase 1 Proteins 0.000 description 1
102100022502 Receptor-interacting serine/threonine-protein kinase 2 Human genes 0.000 description 1
102100037424 Receptor-type tyrosine-protein phosphatase beta Human genes 0.000 description 1
101710101345 Receptor-type tyrosine-protein phosphatase beta Proteins 0.000 description 1
102100032445 Relaxin receptor 2 Human genes 0.000 description 1
101710095753 Relaxin receptor 2 Proteins 0.000 description 1
102000004215 Relaxin receptors Human genes 0.000 description 1
108090000728 Relaxin receptors Proteins 0.000 description 1
102100033912 Retinoic acid receptor gamma Human genes 0.000 description 1
102100038246 Retinol-binding protein 4 Human genes 0.000 description 1
101710137011 Retinol-binding protein 4 Proteins 0.000 description 1
208000025747 Rheumatic disease Diseases 0.000 description 1
108090000621 Ribonuclease P Proteins 0.000 description 1
102000004167 Ribonuclease P Human genes 0.000 description 1
101000944644 Rickettsia typhi (strain ATCC VR-144 / Wilmington) Co-chaperonin GroES Proteins 0.000 description 1
108091006207 SLC-Transporter Proteins 0.000 description 1
102000037054 SLC-Transporter Human genes 0.000 description 1
108091006745 SLC22A12 Proteins 0.000 description 1
108091006296 SLC2A1 Proteins 0.000 description 1
108091007636 SLC54A2 Proteins 0.000 description 1
108091006277 SLC5A1 Proteins 0.000 description 1
108091006269 SLC5A2 Proteins 0.000 description 1
101150099493 STAT3 gene Proteins 0.000 description 1
101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
102400000827 Saposin-D Human genes 0.000 description 1
101800001700 Saposin-D Proteins 0.000 description 1
108091058545 Secretory proteins Proteins 0.000 description 1
102000040739 Secretory proteins Human genes 0.000 description 1
DLSWIYLPEUIQAV-UHFFFAOYSA-N Semaglutide Chemical compound CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(O)=O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(C)(C)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CCCNC(N)=N)C(=O)NCC(O)=O DLSWIYLPEUIQAV-UHFFFAOYSA-N 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
102100026737 Serine/threonine-protein kinase 25 Human genes 0.000 description 1
102100037629 Serine/threonine-protein kinase 4 Human genes 0.000 description 1
101710202845 Serine/threonine-protein kinase 4 Proteins 0.000 description 1
102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
102100034377 Serine/threonine-protein kinase SIK2 Human genes 0.000 description 1
101150018337 Serpinh1 gene Proteins 0.000 description 1
108010029157 Sialic Acid Binding Ig-like Lectin 2 Proteins 0.000 description 1
101000877236 Siganus canaliculatus Acyl-CoA Delta-4 desaturase Proteins 0.000 description 1
102100038081 Signal transducer CD24 Human genes 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
102000011990 Sirtuin Human genes 0.000 description 1
108050002485 Sirtuin Proteins 0.000 description 1
108010041191 Sirtuin 1 Proteins 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
108010052164 Sodium Channels Proteins 0.000 description 1
102000018674 Sodium Channels Human genes 0.000 description 1
102000058090 Sodium-Glucose Transporter 1 Human genes 0.000 description 1
102000058081 Sodium-Glucose Transporter 2 Human genes 0.000 description 1
101710102931 Solute carrier family 22 member 12 Proteins 0.000 description 1
102000013275 Somatomedins Human genes 0.000 description 1
229940123051 Somatostatin receptor agonist Drugs 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
102100037416 Sphingolipid delta(4)-desaturase DES1 Human genes 0.000 description 1
229940090499 Sphingosine kinase 1 inhibitor Drugs 0.000 description 1
229940078053 Sphingosine kinase 2 inhibitor Drugs 0.000 description 1
102100030684 Sphingosine-1-phosphate phosphatase 1 Human genes 0.000 description 1
101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
102000007451 Steroid Receptors Human genes 0.000 description 1
102000000019 Sterol Esterase Human genes 0.000 description 1
108010055297 Sterol Esterase Proteins 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
102100037346 Substance-P receptor Human genes 0.000 description 1
229940100389 Sulfonylurea Drugs 0.000 description 1
102100035721 Syndecan-1 Human genes 0.000 description 1
108090000058 Syndecan-1 Proteins 0.000 description 1
230000020385 T cell costimulation Effects 0.000 description 1
102100036840 T-box transcription factor TBX21 Human genes 0.000 description 1
108010091885 T-box transcription factor TBX21 Proteins 0.000 description 1
102100025131 T-cell differentiation antigen CD6 Human genes 0.000 description 1
101710179381 T-cell differentiation antigen CD6 Proteins 0.000 description 1
102100024219 T-cell surface glycoprotein CD1a Human genes 0.000 description 1
101710127799 T-cell surface glycoprotein CD1a Proteins 0.000 description 1
102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
101150047500 TERT gene Proteins 0.000 description 1
101150000629 TGFB1 gene Proteins 0.000 description 1
101150033527 TNF gene Proteins 0.000 description 1
102100035260 TSC22 domain family protein 3 Human genes 0.000 description 1
102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 1
108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 1
102000006463 Talin Human genes 0.000 description 1
108010083809 Talin Proteins 0.000 description 1
102000045879 Taste receptor type 2 Human genes 0.000 description 1
108091005711 Taste receptors type 2 (bitter) Proteins 0.000 description 1
108010009978 Tec protein-tyrosine kinase Proteins 0.000 description 1
108010017842 Telomerase Proteins 0.000 description 1
102100038126 Tenascin Human genes 0.000 description 1
108010008125 Tenascin Proteins 0.000 description 1
102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 1
108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 1
102100026966 Thrombomodulin Human genes 0.000 description 1
108010079274 Thrombomodulin Proteins 0.000 description 1
108010046075 Thymosin Proteins 0.000 description 1
102000007501 Thymosin Human genes 0.000 description 1
229940127535 Thyroid Hormone Receptor Agonists Drugs 0.000 description 1
102100033451 Thyroid hormone receptor beta Human genes 0.000 description 1
102100039360 Toll-like receptor 4 Human genes 0.000 description 1
239000000317 Topoisomerase II Inhibitor Substances 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
108090000340 Transaminases Proteins 0.000 description 1
102000003929 Transaminases Human genes 0.000 description 1
108010031154 Transcription Factor RelA Proteins 0.000 description 1
102100032727 Transcription factor RelB Human genes 0.000 description 1
108090000952 Transcription factor RelB Proteins 0.000 description 1
102100035100 Transcription factor p65 Human genes 0.000 description 1
102000004338 Transferrin Human genes 0.000 description 1
108090000901 Transferrin Proteins 0.000 description 1
108010082684 Transforming Growth Factor-beta Type II Receptor Proteins 0.000 description 1
102000004060 Transforming Growth Factor-beta Type II Receptor Human genes 0.000 description 1
102000056172 Transforming growth factor beta-3 Human genes 0.000 description 1
108090000097 Transforming growth factor beta-3 Proteins 0.000 description 1
108060008539 Transglutaminase Proteins 0.000 description 1
206010052779 Transplant rejections Diseases 0.000 description 1
TZIZWYVVGLXXFV-FLRHRWPCSA-N Triamcinolone hexacetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@@H]2O TZIZWYVVGLXXFV-FLRHRWPCSA-N 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
102100040653 Tryptophan 2,3-dioxygenase Human genes 0.000 description 1
101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 description 1
102100024971 Tryptophan 5-hydroxylase 1 Human genes 0.000 description 1
101710124006 Tryptophan 5-hydroxylase 1 Proteins 0.000 description 1
102000004243 Tubulin Human genes 0.000 description 1
108090000704 Tubulin Proteins 0.000 description 1
102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
108010045627 Type I Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Proteins 0.000 description 1
102100033019 Tyrosine-protein phosphatase non-receptor type 11 Human genes 0.000 description 1
102100033014 Tyrosine-protein phosphatase non-receptor type 13 Human genes 0.000 description 1
102100040052 Ubiquitin carboxyl-terminal hydrolase 30 Human genes 0.000 description 1
101710091180 Ubiquitin carboxyl-terminal hydrolase 30 Proteins 0.000 description 1
102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 1
108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 1
108010073925 Vascular Endothelial Growth Factor B Proteins 0.000 description 1
102100038217 Vascular endothelial growth factor B Human genes 0.000 description 1
102100038388 Vasoactive intestinal polypeptide receptor 1 Human genes 0.000 description 1
101710137655 Vasoactive intestinal polypeptide receptor 1 Proteins 0.000 description 1
102100038286 Vasoactive intestinal polypeptide receptor 2 Human genes 0.000 description 1
101710137651 Vasoactive intestinal polypeptide receptor 2 Proteins 0.000 description 1
102000004136 Vasopressin Receptors Human genes 0.000 description 1
108090000643 Vasopressin Receptors Proteins 0.000 description 1
102100029477 Vitamin K-dependent protein C Human genes 0.000 description 1
101710193900 Vitamin K-dependent protein C Proteins 0.000 description 1
FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 1
101150094313 XPO1 gene Proteins 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
IUEWXNHSKRWHDY-PHIMTYICSA-N abrocitinib Chemical compound C1[C@@H](NS(=O)(=O)CCC)C[C@H]1N(C)C1=NC=NC2=C1C=CN2 IUEWXNHSKRWHDY-PHIMTYICSA-N 0.000 description 1
229940121519 abrocitinib Drugs 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
229960002632 acarbose Drugs 0.000 description 1
XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
MGVGMXLGOKTYKP-ZFOBEOMCSA-N acetic acid;(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-one Chemical compound CC(O)=O.C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 MGVGMXLGOKTYKP-ZFOBEOMCSA-N 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
229940119059 actemra Drugs 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000011149 active material Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
150000001263 acyl chlorides Chemical class 0.000 description 1
150000001266 acyl halides Chemical class 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
239000002487 adenosine deaminase inhibitor Substances 0.000 description 1
229940121359 adenosine receptor antagonist Drugs 0.000 description 1
102000030621 adenylate cyclase Human genes 0.000 description 1
108060000200 adenylate cyclase Proteins 0.000 description 1
108010087178 adiponutrin Proteins 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000003470 adrenal cortex hormone Substances 0.000 description 1
239000000048 adrenergic agonist Substances 0.000 description 1
229940126157 adrenergic receptor agonist Drugs 0.000 description 1
ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
101150045355 akt1 gene Proteins 0.000 description 1
229960004733 albiglutide Drugs 0.000 description 1
OGWAVGNOAMXIIM-UHFFFAOYSA-N albiglutide Chemical compound O=C(O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)CNC(=O)C(N)CC=1(N=CNC=1))CCC(=O)O)C(O)C)CC2(=CC=CC=C2))C(O)C)CO)CC(=O)O)C(C)C)CO)CO)CC3(=CC=C(O)C=C3))CC(C)C)CCC(=O)O)CCC(=O)N)C)C)CCCCN)CCC(=O)O)CC4(=CC=CC=C4))C(CC)C)C)CC=6(C5(=C(C=CC=C5)NC=6)))CC(C)C)C(C)C)CCCCN)CCCNC(=N)N OGWAVGNOAMXIIM-UHFFFAOYSA-N 0.000 description 1
108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 1
229940083712 aldosterone antagonist Drugs 0.000 description 1
239000002170 aldosterone antagonist Substances 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
150000004703 alkoxides Chemical class 0.000 description 1
229960001667 alogliptin Drugs 0.000 description 1
ZSBOMTDTBDDKMP-OAHLLOKOSA-N alogliptin Chemical compound C=1C=CC=C(C#N)C=1CN1C(=O)N(C)C(=O)C=C1N1CCC[C@@H](N)C1 ZSBOMTDTBDDKMP-OAHLLOKOSA-N 0.000 description 1
108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
102000015395 alpha 1-Antitrypsin Human genes 0.000 description 1
229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
102000013529 alpha-Fetoproteins Human genes 0.000 description 1
108010026331 alpha-Fetoproteins Proteins 0.000 description 1
229960000711 alprostadil Drugs 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000003708 ampul Substances 0.000 description 1
108091005466 amylin receptors Proteins 0.000 description 1
229960004238 anakinra Drugs 0.000 description 1
239000003098 androgen Substances 0.000 description 1
239000003936 androgen receptor antagonist Substances 0.000 description 1
229950006323 angiotensin ii Drugs 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000078 anti-malarial effect Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000003529 anticholesteremic agent Substances 0.000 description 1
229940127226 anticholesterol agent Drugs 0.000 description 1
229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000003430 antimalarial agent Substances 0.000 description 1
229940033495 antimalarials Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229940064004 antiseptic throat preparations Drugs 0.000 description 1
238000003782 apoptosis assay Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
229940059756 arava Drugs 0.000 description 1
238000011914 asymmetric synthesis Methods 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
230000004900 autophagic degradation Effects 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
238000000498 ball milling Methods 0.000 description 1
229960004168 balsalazide Drugs 0.000 description 1
IPOKCKJONYRRHP-FMQUCBEESA-N balsalazide Chemical compound C1=CC(C(=O)NCCC(=O)O)=CC=C1\N=N\C1=CC=C(O)C(C(O)=O)=C1 IPOKCKJONYRRHP-FMQUCBEESA-N 0.000 description 1
229950000971 baricitinib Drugs 0.000 description 1
XUZMWHLSFXCVMG-UHFFFAOYSA-N baricitinib Chemical compound C1N(S(=O)(=O)CC)CC1(CC#N)N1N=CC(C=2C=3C=CNC=3N=CN=2)=C1 XUZMWHLSFXCVMG-UHFFFAOYSA-N 0.000 description 1
108700000707 bcl-2-Associated X Proteins 0.000 description 1
102000055102 bcl-2-Associated X Human genes 0.000 description 1
239000000759 benzodiazepine receptor stimulating agent Substances 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
102000006635 beta-lactamase Human genes 0.000 description 1
229960001102 betamethasone dipropionate Drugs 0.000 description 1
CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
230000037396 body weight Effects 0.000 description 1
229940112869 bone morphogenetic protein Drugs 0.000 description 1
101150048834 braF gene Proteins 0.000 description 1
229940125763 bromodomain inhibitor Drugs 0.000 description 1
229960004436 budesonide Drugs 0.000 description 1
FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
229910000024 caesium carbonate Inorganic materials 0.000 description 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
229960004015 calcitonin Drugs 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229960001713 canagliflozin Drugs 0.000 description 1
VHOFTEAWFCUTOS-TUGBYPPCSA-N canagliflozin hydrate Chemical compound O.CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1.CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1 VHOFTEAWFCUTOS-TUGBYPPCSA-N 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000003555 cannabinoid 1 receptor antagonist Substances 0.000 description 1
239000003556 cannabinoid 2 receptor agonist Substances 0.000 description 1
229940121376 cannabinoid receptor agonist Drugs 0.000 description 1
239000003537 cannabinoid receptor agonist Substances 0.000 description 1
239000003536 cannabinoid receptor antagonist Substances 0.000 description 1
229960002504 capsaicin Drugs 0.000 description 1
235000017663 capsaicin Nutrition 0.000 description 1
230000023852 carbohydrate metabolic process Effects 0.000 description 1
235000021256 carbohydrate metabolism Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000003489 carbonate dehydratase inhibitor Substances 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
229940105329 carboxymethylcellulose Drugs 0.000 description 1
229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 description 1
239000000969 carrier Substances 0.000 description 1
229960000590 celecoxib Drugs 0.000 description 1
RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
229940107810 cellcept Drugs 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
239000007958 cherry flavor Substances 0.000 description 1
239000012069 chiral reagent Substances 0.000 description 1
108010089807 chitosanase Proteins 0.000 description 1
239000003467 chloride channel stimulating agent Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
239000003754 cholecystokinin receptor blocking agent Substances 0.000 description 1
229940080701 chymosin Drugs 0.000 description 1
229940090100 cimzia Drugs 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000002442 collagenase inhibitor Substances 0.000 description 1
229940075614 colloidal silicon dioxide Drugs 0.000 description 1
230000024203 complement activation Effects 0.000 description 1
229940121388 complement c3 inhibitor Drugs 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
238000013329 compounding Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000010949 copper Substances 0.000 description 1
108091008723 corticosteroid receptors Proteins 0.000 description 1
IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
229960004544 cortisone Drugs 0.000 description 1
239000006071 cream Substances 0.000 description 1
USZAGAREISWJDP-UHFFFAOYSA-N crisaborole Chemical compound C=1C=C2B(O)OCC2=CC=1OC1=CC=C(C#N)C=C1 USZAGAREISWJDP-UHFFFAOYSA-N 0.000 description 1
229950008199 crisaborole Drugs 0.000 description 1
229960000913 crospovidone Drugs 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
229940121384 cxc chemokine receptor type 4 (cxcr4) antagonist Drugs 0.000 description 1
239000003260 cyclooxygenase 1 inhibitor Substances 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
229960003834 dapagliflozin Drugs 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
238000003795 desorption Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
229910052805 deuterium Inorganic materials 0.000 description 1
229960003957 dexamethasone Drugs 0.000 description 1
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
229940038472 dicalcium phosphate Drugs 0.000 description 1
229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
229960001259 diclofenac Drugs 0.000 description 1
DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
XSDVOEIEBUGRQX-RBUKOAKNSA-N dihydroceramide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC=O XSDVOEIEBUGRQX-RBUKOAKNSA-N 0.000 description 1
108020001096 dihydrofolate reductase Proteins 0.000 description 1
239000003363 dihydroorotate dehydrogenase inhibitor Substances 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
JIWJMBWJUBGXRA-UIHQBSCNSA-L disodium;1-[(8s,9r,10s,11s,13s,14s,16s,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]butane-1,3-dione;[2-[(8s,9r,10s,11s,13s,14s,16s,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-o Chemical compound [Na+].[Na+].C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CC(C)=O)(O)[C@@]1(C)C[C@@H]2O.C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COP([O-])([O-])=O)(O)[C@@]1(C)C[C@@H]2O JIWJMBWJUBGXRA-UIHQBSCNSA-L 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000002612 dispersion medium Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000003968 dna methyltransferase inhibitor Substances 0.000 description 1
229940126534 drug product Drugs 0.000 description 1
230000008406 drug-drug interaction Effects 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
229960005175 dulaglutide Drugs 0.000 description 1
108010005794 dulaglutide Proteins 0.000 description 1
229960002866 duloxetine Drugs 0.000 description 1
229950003468 dupilumab Drugs 0.000 description 1
229960003345 empagliflozin Drugs 0.000 description 1
OBWASQILIWPZMG-QZMOQZSNSA-N empagliflozin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=CC=C(Cl)C(CC=2C=CC(O[C@@H]3COCC3)=CC=2)=C1 OBWASQILIWPZMG-QZMOQZSNSA-N 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
229940073621 enbrel Drugs 0.000 description 1
108010022937 endoplasmin Proteins 0.000 description 1
108010018033 endothelial PAS domain-containing protein 1 Proteins 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
239000002792 enkephalinase inhibitor Substances 0.000 description 1
229940125532 enzyme inhibitor Drugs 0.000 description 1
210000003979 eosinophil Anatomy 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
238000011067 equilibration Methods 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
230000000925 erythroid effect Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
230000029142 excretion Effects 0.000 description 1
229960001519 exenatide Drugs 0.000 description 1
239000010685 fatty oil Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
230000002550 fecal effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
101150015947 fimH gene Proteins 0.000 description 1
229950004408 finerenone Drugs 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
229940043075 fluocinolone Drugs 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
239000004052 folic acid antagonist Substances 0.000 description 1
230000009246 food effect Effects 0.000 description 1
235000021471 food effect Nutrition 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000019264 food flavour enhancer Nutrition 0.000 description 1
238000001640 fractional crystallisation Methods 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
210000004211 gastric acid Anatomy 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
229960004666 glucagon Drugs 0.000 description 1
239000003877 glucagon like peptide 1 receptor agonist Substances 0.000 description 1
239000003292 glue Substances 0.000 description 1
230000000848 glutamatergic effect Effects 0.000 description 1
108010051015 glutathione-independent formaldehyde dehydrogenase Proteins 0.000 description 1
230000002641 glycemic effect Effects 0.000 description 1
239000002748 glycoprotein P inhibitor Substances 0.000 description 1
239000003979 granulating agent Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
239000007902 hard capsule Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
239000003481 heat shock protein 90 inhibitor Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
108700012707 hepatitis C virus NS3 Proteins 0.000 description 1
239000000938 histamine H1 antagonist Substances 0.000 description 1
239000003396 histamine H4 receptor antagonist Substances 0.000 description 1
229940077716 histamine h2 receptor antagonists for peptic ulcer and gord Drugs 0.000 description 1
VYLJAYXZTOTZRR-UHFFFAOYSA-N hopane-6alpha,7beta,22-triol Natural products C12CCC3C4(C)CCCC(C)(C)C4C(O)C(O)C3(C)C1(C)CCC1C2(C)CCC1C(C)(O)C VYLJAYXZTOTZRR-UHFFFAOYSA-N 0.000 description 1
229940048921 humira Drugs 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
239000002955 immunomodulating agent Substances 0.000 description 1
229940121354 immunomodulator Drugs 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
229940124589 immunosuppressive drug Drugs 0.000 description 1
229940073062 imuran Drugs 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
229910052738 indium Inorganic materials 0.000 description 1
APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
239000002348 inosinate dehydrogenase inhibitor Substances 0.000 description 1
108010024069 integrin alpha9 Proteins 0.000 description 1
108010021309 integrin beta6 Proteins 0.000 description 1
108010021315 integrin beta7 Proteins 0.000 description 1
108010021506 integrin beta8 Proteins 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
108010085650 interferon gamma receptor Proteins 0.000 description 1
229960001388 interferon-beta Drugs 0.000 description 1
102000002467 interleukin receptors Human genes 0.000 description 1
108010093036 interleukin receptors Proteins 0.000 description 1
108010074108 interleukin-21 Proteins 0.000 description 1
239000011872 intimate mixture Substances 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
229940126181 ion channel inhibitor Drugs 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000007951 isotonicity adjuster Substances 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
229940078795 lactoferrin Drugs 0.000 description 1
235000021242 lactoferrin Nutrition 0.000 description 1
239000008101 lactose Substances 0.000 description 1
229960001375 lactose Drugs 0.000 description 1
229960001021 lactose monohydrate Drugs 0.000 description 1
MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 1
101150041530 ldha gene Proteins 0.000 description 1
108010072713 leukotriene A4 hydrolase Proteins 0.000 description 1
YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 description 1
229940065725 leukotriene receptor antagonists for obstructive airway diseases Drugs 0.000 description 1
239000003199 leukotriene receptor blocking agent Substances 0.000 description 1
150000002617 leukotrienes Chemical class 0.000 description 1
XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
229960002397 linagliptin Drugs 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
229960002701 liraglutide Drugs 0.000 description 1
101150004907 litaf gene Proteins 0.000 description 1
XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
229910052808 lithium carbonate Inorganic materials 0.000 description 1
LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
239000000766 liver X receptor agonist Substances 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
229960001093 lixisenatide Drugs 0.000 description 1
108010004367 lixisenatide Proteins 0.000 description 1
238000011068 loading method Methods 0.000 description 1
101150062900 lpl gene Proteins 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
239000002697 lyase inhibitor Substances 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
229940124302 mTOR inhibitor Drugs 0.000 description 1
KWORUUGOSLYAGD-UHFFFAOYSA-N magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-ide Chemical compound [Mg+2].N=1C2=CC(OC)=CC=C2[N-]C=1S(=O)CC1=NC=C(C)C(OC)=C1C.N=1C2=CC(OC)=CC=C2[N-]C=1S(=O)CC1=NC=C(C)C(OC)=C1C KWORUUGOSLYAGD-UHFFFAOYSA-N 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000003628 mammalian target of rapamycin inhibitor Substances 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
229960001855 mannitol Drugs 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
229940121386 matrix metalloproteinase inhibitor Drugs 0.000 description 1
239000003771 matrix metalloproteinase inhibitor Substances 0.000 description 1
101150094281 mcl1 gene Proteins 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
229960003105 metformin Drugs 0.000 description 1
229960001293 methylprednisolone acetate Drugs 0.000 description 1
108091062762 miR-21 stem-loop Proteins 0.000 description 1
108091041631 miR-21-1 stem-loop Proteins 0.000 description 1
108091044442 miR-21-2 stem-loop Proteins 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
229960001110 miglitol Drugs 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229950000844 mizoribine Drugs 0.000 description 1
SLZIZIJTGAYEKK-CIJSCKBQSA-N molport-023-220-247 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CNC=N1 SLZIZIJTGAYEKK-CIJSCKBQSA-N 0.000 description 1
PXZWGQLGAKCNKD-DPNMSELWSA-N molport-023-276-326 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 PXZWGQLGAKCNKD-DPNMSELWSA-N 0.000 description 1
239000002899 monoamine oxidase inhibitor Substances 0.000 description 1
150000004682 monohydrates Chemical group 0.000 description 1
229940014456 mycophenolate Drugs 0.000 description 1
229960000951 mycophenolic acid Drugs 0.000 description 1
210000005012 myelin Anatomy 0.000 description 1
GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
229960004270 nabumetone Drugs 0.000 description 1
229960002009 naproxen Drugs 0.000 description 1
CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 description 1
229960005027 natalizumab Drugs 0.000 description 1
230000017128 negative regulation of NF-kappaB transcription factor activity Effects 0.000 description 1
108010027531 nephrin Proteins 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
102000037979 non-receptor tyrosine kinases Human genes 0.000 description 1
108091008046 non-receptor tyrosine kinases Proteins 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
238000010943 off-gassing Methods 0.000 description 1
239000002674 ointment Substances 0.000 description 1
229960004110 olsalazine Drugs 0.000 description 1
QQBDLJCYGRGAKP-FOCLMDBBSA-N olsalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=C(C(O)=CC=2)C(O)=O)=C1 QQBDLJCYGRGAKP-FOCLMDBBSA-N 0.000 description 1
SBQLYHNEIUGQKH-UHFFFAOYSA-N omeprazole Chemical compound N1=C2[CH]C(OC)=CC=C2N=C1S(=O)CC1=NC=C(C)C(OC)=C1C SBQLYHNEIUGQKH-UHFFFAOYSA-N 0.000 description 1
229960000381 omeprazole Drugs 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000007968 orange flavor Substances 0.000 description 1
229940035567 orencia Drugs 0.000 description 1
102000004164 orphan nuclear receptors Human genes 0.000 description 1
108090000629 orphan nuclear receptors Proteins 0.000 description 1
230000004072 osteoblast differentiation Effects 0.000 description 1
238000000643 oven drying Methods 0.000 description 1
239000002457 oxidoreductase inhibitor Substances 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
229960005019 pantoprazole Drugs 0.000 description 1
229960005489 paracetamol Drugs 0.000 description 1
239000000199 parathyroid hormone Substances 0.000 description 1
229960001319 parathyroid hormone Drugs 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
239000002935 phosphatidylinositol 3 kinase inhibitor Substances 0.000 description 1
108010016216 phosphatidylinositol receptors Proteins 0.000 description 1
239000002570 phosphodiesterase III inhibitor Substances 0.000 description 1
239000002587 phosphodiesterase IV inhibitor Substances 0.000 description 1
239000002590 phosphodiesterase V inhibitor Substances 0.000 description 1
239000002571 phosphodiesterase inhibitor Substances 0.000 description 1
229940043441 phosphoinositide 3-kinase inhibitor Drugs 0.000 description 1
239000003358 phospholipase A2 inhibitor Substances 0.000 description 1
239000003371 phospholipase C inhibitor Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
KASDHRXLYQOAKZ-ZPSXYTITSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-ZPSXYTITSA-N 0.000 description 1
229960005330 pimecrolimus Drugs 0.000 description 1
229960003073 pirfenidone Drugs 0.000 description 1
ISWRGOKTTBVCFA-UHFFFAOYSA-N pirfenidone Chemical compound C1=C(C)C=CC(=O)N1C1=CC=CC=C1 ISWRGOKTTBVCFA-UHFFFAOYSA-N 0.000 description 1
229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
102000030769 platelet activating factor receptor Human genes 0.000 description 1
102000002022 plexin Human genes 0.000 description 1
108050009312 plexin Proteins 0.000 description 1
229960000502 poloxamer Drugs 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
229940050929 polyethylene glycol 3350 Drugs 0.000 description 1
229940068918 polyethylene glycol 400 Drugs 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229950008882 polysorbate Drugs 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
238000002600 positron emission tomography Methods 0.000 description 1
229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
235000015497 potassium bicarbonate Nutrition 0.000 description 1
239000011736 potassium bicarbonate Substances 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
235000011181 potassium carbonates Nutrition 0.000 description 1
108020001213 potassium channel Proteins 0.000 description 1
NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
229910000105 potassium hydride Inorganic materials 0.000 description 1
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
229940069328 povidone Drugs 0.000 description 1
239000002243 precursor Substances 0.000 description 1
229960005205 prednisolone Drugs 0.000 description 1
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
229940032668 prevacid Drugs 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
238000004886 process control Methods 0.000 description 1
229940002612 prodrug Drugs 0.000 description 1
239000000651 prodrug Substances 0.000 description 1
229940072288 prograf Drugs 0.000 description 1
230000005522 programmed cell death Effects 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 description 1
GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 description 1
235000019419 proteases Nutrition 0.000 description 1
239000003207 proteasome inhibitor Substances 0.000 description 1
229940076372 protein antagonist Drugs 0.000 description 1
229960000856 protein c Drugs 0.000 description 1
230000006916 protein interaction Effects 0.000 description 1
239000003801 protein tyrosine phosphatase 1B inhibitor Substances 0.000 description 1
229940126409 proton pump inhibitor Drugs 0.000 description 1
239000000612 proton pump inhibitor Substances 0.000 description 1
229940061276 protonix Drugs 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
239000003379 purinergic P1 receptor agonist Substances 0.000 description 1
239000000296 purinergic P1 receptor antagonist Substances 0.000 description 1
239000003227 purinergic agonist Substances 0.000 description 1
108700027806 rGLP-1 Proteins 0.000 description 1
230000005855 radiation Effects 0.000 description 1
108700042226 ras Genes Proteins 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
239000003642 reactive oxygen metabolite Substances 0.000 description 1
108091006073 receptor regulators Proteins 0.000 description 1
229940116176 remicade Drugs 0.000 description 1
102000003702 retinoic acid receptors Human genes 0.000 description 1
108090000064 retinoic acid receptors Proteins 0.000 description 1
108091008760 retinoic acid receptors γ Proteins 0.000 description 1
230000000552 rheumatic effect Effects 0.000 description 1
239000003419 rna directed dna polymerase inhibitor Substances 0.000 description 1
229960000215 ruxolitinib Drugs 0.000 description 1
HFNKQEVNSGCOJV-OAHLLOKOSA-N ruxolitinib Chemical compound C1([C@@H](CC#N)N2N=CC(=C2)C=2C=3C=CNC=3N=CN=2)CCCC1 HFNKQEVNSGCOJV-OAHLLOKOSA-N 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
229960004937 saxagliptin Drugs 0.000 description 1
QGJUIPDUBHWZPV-SGTAVMJGSA-N saxagliptin Chemical compound C1C(C2)CC(C3)CC2(O)CC13[C@H](N)C(=O)N1[C@H](C#N)C[C@@H]2C[C@@H]21 QGJUIPDUBHWZPV-SGTAVMJGSA-N 0.000 description 1
108010033693 saxagliptin Proteins 0.000 description 1
230000007017 scission Effects 0.000 description 1
208000010157 sclerosing cholangitis Diseases 0.000 description 1
108010060325 semaglutide Proteins 0.000 description 1
229950011186 semaglutide Drugs 0.000 description 1
229940068638 simponi Drugs 0.000 description 1
229960004034 sitagliptin Drugs 0.000 description 1
MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
239000012312 sodium hydride Substances 0.000 description 1
229910000104 sodium hydride Inorganic materials 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
108010003524 sodium-bile acid cotransporter Proteins 0.000 description 1
239000007901 soft capsule Substances 0.000 description 1
241000894007 species Species 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
108010066791 sphingosine-1-phosphate phosphatase Proteins 0.000 description 1
239000007921 spray Substances 0.000 description 1
108010087686 src-Family Kinases Proteins 0.000 description 1
102000009076 src-Family Kinases Human genes 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000000021 stimulant Substances 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000004441 surface measurement Methods 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
229940037128 systemic glucocorticoids Drugs 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
238000002626 targeted therapy Methods 0.000 description 1
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
150000004685 tetrahydrates Chemical class 0.000 description 1
230000004797 therapeutic response Effects 0.000 description 1
LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
108091008762 thyroid hormone receptors ß Proteins 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
229960004380 tramadol Drugs 0.000 description 1
TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 description 1
239000003558 transferase inhibitor Substances 0.000 description 1
239000012581 transferrin Substances 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
102000003601 transglutaminase Human genes 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
229960005294 triamcinolone Drugs 0.000 description 1
GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
229940126307 triamcinolone acetate Drugs 0.000 description 1
229960004221 triamcinolone hexacetonide Drugs 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
102000015533 trkA Receptor Human genes 0.000 description 1
108010064884 trkA Receptor Proteins 0.000 description 1
239000002447 tumor necrosis factor alpha converting enzyme inhibitor Substances 0.000 description 1
229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 description 1
239000002451 tumor necrosis factor inhibitor Substances 0.000 description 1
230000006433 tumor necrosis factor production Effects 0.000 description 1
230000005751 tumor progression Effects 0.000 description 1
150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
229960003824 ustekinumab Drugs 0.000 description 1
229960004914 vedolizumab Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
229940123713 vimentin inhibitor Drugs 0.000 description 1
229960001729 voglibose Drugs 0.000 description 1
BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 description 1
229960004740 voriconazole Drugs 0.000 description 1
238000005303 weighing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000003064 xanthine oxidase inhibitor Substances 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
108010027843 zonulin Proteins 0.000 description 1